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It is demonstrated that NMR spectroscopy is a powerful technique for separating and 
measuring each distinct pKa value of the amino groups located around aminoglycoside 
antibiotics. Unambiguous assignments were made for each individual amine and guanidine 
substituent on:  2-deoxystreptamine, neamine, neomycin C, paromomycin, tobramycin, 
kanamycin B, netilmicin, sisomicin, amikacin, and streptomycin using variations in the NMR 
spectroscopic chemical shift () with 1H, 13C, and 15N HMBC as the reporter probes. These 
data were then compared with the literature data. Minor revisions to the assignment order were 
made for neomycin C and paromomycin. pKa values for kanamycin B have been reported using 
potentiometry, however no NMR derived pKa data have been reported, and for netilmicin no 
literature pKa values were found. Therefore, these data are reported for the first time herein. 
Due to its sensitivity and natural abundance (99.98%), 1H NMR is less time consuming 
than 13C and 15N HMBC NMR spectroscopy. For this reason, 1H NMR is the most common 
and preferable method for measuring individual pKa values. 
One of the ultimate objectives of this line of research is to be able to trace an 
aminoglycoside, e.g., tobramycin, in the body in a non-invasive way by tagging the 
aminoglycoside with a fluorescent probe. Taking both the pKa values of the individual amino 
functional groups of tobramycin and steric-hindrance factors into consideration, the 
investigation of the specific or selective reactions of the different amines located around 
tobramycin were carried out with amino acid protecting groups, e.g., Boc and Cbz, and with a 
fluorophore (FITC) that would generate a biologically relevant tagged product. Four out of 
five amines on tobramycin were protected with Boc protecting groups. However, the mono-
protection of tobramycin with Boc or Cbz groups and labelling the unprotected (unreacted) N-
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d     Doublet 
equiv.    Equivalent 
ESI     Electrospray ionisation 
FITC    Fluorescein isothiocyanate 
g     gram 
HMBC    Heteronuclear multiple bond correlation 
HR TOF    High resolution time-of-flight 
HRMS    High resolution mass spectrometry 
HSQC    Heteronuclear single quantum correlation 
Hz     Hertz 
M     Molar (moles per litre) 
m     Multiplet 
mmol     Millimoles 
NMR    Nuclear magnetic resonance 
NOESY   Nuclear Overhauser spectroscopy 
pKa     Ionisation constant of the conjugate acid 
ppm     Parts per million 
q     Quartet 
Rf     Retention factor 
RNA     Ribonucleic acid 
rRNA     Ribosomal ribonucleic acid 
s     Singlet 
t     Triplet 
TLC     Thin layer chromatography 
UV     Ultraviolet 
v/v     Volume/volume 
WHO    World Health Organisation 
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1.1.1. General Introduction to Aminoglycoside Antibiotics 
 
By definition, natural products are any product that has been isolated or produced from 
microorganisms, animals or plants present in nature (Schoental, 1965; Gad, 2005; Armstrong 
et al., 2012). According to the World Health Organization (WHO), more than 80% of the 
world’s population relies on natural products through traditional or alternative medicines for 
their healthcare (Farnsworth et al., 1985). More than 100 of the chemical substances currently 
in use have been isolated from natural sources such as plants and/or microorganisms. One 
example of such a natural products class are the aminoglycosides (Cragg and Newman, 2001; 
Gad, 2005). 
Aminoglycosides are compounds which consist of an aminocyclitol moiety 2-
deoxystreptamine (1) or streptidine ring in streptomycin (10) (see Fig. 1.1 and Fig. 1.3) 
attached to amino sugars by glycosidic bonds. These compounds are primarily used for the 
treatment of infection by Gram-negative (aerobic) and other Gram-positive bacteria (Seiler et 







1.1.2. History of Aminoglycoside Antibiotics 
 
There are many drug subtypes in aminoglycosides, including: neomycin C (3), 
paromomycin (4), tobramycin (5), kanamycin B (6), netilmicin (7), sisomicin (8), amikacin 
(9), and streptomycin (10), (see Fig. 1.1, 1.2, and 1.3). They occur both naturally and in the 
form of semi-synthetic compounds (Weisblum and Davies, 1968; Shah et al., 1977; Whelton 
and Neu, 1982; Hofer, 2013). These antimicrobial agents were first discovered in 1944 from 
the organism Streptomyces griseus. Streptomycin (10) and neomycin (3) were revealed by 
American biochemists Selman Waksman, Elizabeth Bugie, and Albert Schatz from bacteria in 
the soil (Schatz et al., 1944; Beale et al., 2010; Armstrong et al., 2012). 
The first drug in the aminoglycoside series was streptomycin (10). It is efficacious in the 
treatment of tuberculosis (Tb) which was previously a life-threatening condition. New 
members in the aminoglycoside series, e.g., kanamycin B (6) and tobramycin (5), continue to 
contribute to healthcare. In the 1970s, other agents, namely dibekacin, amikacin, and 
netilmicin (7), were also introduced; these are semi-synthetic aminoglycosides (Avent et al., 
2011). 
Aminoglycoside antibiotics comprising of neomycin (3), introduced in 1949, paromomycin 
(4), introduced in 1956, kanamycin B (6), introduced in 1957, gentamicin (11), introduced in 
1963, tobramycin (5), introduced in 1967, and sisomicin (8), introduced in 1970, and (Table 
1.1). All of these drugs have shown great potential for halting the activity of Gram-negative 
bacteria, such as Pseudomonas aeruginosa and some Gram-positive bacteria, such as 
Staphylococcus aureus (Schatz et al., 1944; Waksman and Lechevalier, 1949; Armstrong et 
al., 2012; Becker and Cooper, 2013). New semi-synthetic drugs were introduced because 
bacteria were becoming resistant to the previous aminoglycosides. A situation which, if 
anything, is even worse today with the rise of superbugs and antimicrobial resistance on a 
global scale. Antimicrobial resistance has been caused by the poor stewardship of antibiotics 
and we are at risk of entering the post-antibiotic era. Therefore, a more detailed, scientific 
understanding of antibiotics will help in the discovery of more and potentially better 
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antibiotics. The new semi-synthetic drugs had better pharmacological profiles than the 
previous aminoglycosides and were called the second generation of aminoglycosides. These 
included the following: dibekacin, introduced in 1971, amikacin, introduced in 1972, 
arbekacin, discovered in 1973, isepamicin, discovered in 1975, and netilmicin (7), discovered 
in 1976. It was also found that the newly developed semi-synthetic aminoglycosides, 
especially amikacin, were less susceptible to targeting by aminoglycoside-modifying enzymes 
(AMEs) (Becker and Cooper, 2013). 
 
Table 1.1 Year of discovery, source, and the spectrum of activity of selected aminoglycosides 
Aminoglycoside Discovery Source Spectrum of activity  
streptomycin (10) 1944 Streptomyces griseus Mycobacterium 
tuberculosis 
neomycin (3) 1949 Streptomyces fradiae Enterobacteriaceae spp 
paromomycin (4) 1956 Streptomyces rimosusas Protozoa 
kanamycin B (6) 1957 Streptomyces kanamyceticus Enterobacteriaceae spp 
gentamicin (11) 1963 Micromonospora purpurea Pseudomonas 
tobramycin (5) 1967 Streptomyces tenebrarius Pseudomonas 




























Fig. 1.3 Amikacin (9), streptomycin (10), gentamicin (11). 
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1.1.3. Mechanism of Action of Aminoglycosides 
 
The mechanism of action of aminoglycosides allows them to attack the aerobic, Gram-
negative bacteria (Foye et al., 2008; Beale et al., 2010; Becker and Cooper, 2013; Watkins et 
al., 2013). The mechanism was identified in 1980, where it was found that they act on the 16S 
rRNA subunit of the 30S bacterial ribosome (Moazed and Noller, 1987; Kong et al., 2016). 
Since then, there has been extensive research to identify the various methods with which 
aminoglycosides attack bacteria. The general mechanism of the action of aminoglycosides 
resides in their ability to displace adenine from the three unpaired adenine residues in the 
decoding loops. This causes an orientation into a flipped-out position and consequentially, the 
development of non-functional protein synthesis, leading to cell death, shown in Fig. 1.4 
(Vicens and Westhof, 2003; Ogle and Ramakrishnan, 2005; Kulik et al., 2015). 
  
 
Fig. 1.4 Neomycin B binds to 16S RNA ribosomes at the A-site of the 30S ribosomal subunit 




The binding of aminoglycosides to RNA is associated with the interaction of the amino 
groups of aminoglycosides, which are positively charged, and the anionic phosphate groups 
of RNA (Wang and Tor, 1997). The other source of interaction occurs because of the hydrogen 
bonding between different hydroxyl and amino groups of aminoglycosides and RNA (Jiang 
and Patel, 1998; François et al., 2005; Hobbie et al., 2006). All of these interactions result in 
a bond between RNA and aminoglycosides which results in a decline in the translation activity 
of bacterial RNA.  
The introduction of L-4-amino-2-hydroxybutanoic acid (L-AHBA) on the N-1-position of 
the 2-deoxystreptamine ring on amikacin (9) (see Fig. 1.3) was found to be efficacious in 
improving the attacking profile of aminoglycosides on the bacteria. Adding L-AHBA can 
make a stronger bond with the A-site of the RNA of the bacteria. Moreover, a primary amine 
present in the L-AHBA on amikacin, another domain for the interaction with the phosphate of 
RNA of bacteria, results in strong bonding (Russell et al., 2003). An analogue of tobramycin 
(5) has been introduced that has shown great efficacy against bacteria that produce 
aminoglycoside-modifying enzymes. 6′′-Thioether-tobramycin attacks the bacterial cell 
membranes rather than the protein synthesis process (Herzog et al., 2012). An important aspect 
for the clinical use of aminoglycosides is their potential use in human immunodeficiency virus 
(HIV) treatment as they can target many important sites in the HIV life cycle (Houghton et al., 
2010). This has led to a developing interest among researchers to look for ways to treat patients 
with HIV using aminoglycosides. Aminoglycoside–polyarginine conjugates (APArC) and 
aminoglycoside–arginine conjugates (AArC) are some of the compounds under consideration 
for the treatment of HIV (Hegde et al., 2007; Lapidot et al., 2008; Mousseau et al., 2015). 
 
1.1.4. Spectrum of Activity of Aminoglycosides 
 
The spectrum of activity means the ability of the antibiotic to target organisms, specifically 
it is defined as the efficacy of the drug to target certain organisms (Armstrong et al., 2012; 
Carpenter et al., 2012). Narrow-spectrum antibiotics include streptomycin (10). These are 
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effective against Gram-negative organisms, such as Salmonella species, Pseudomonas 
aeruginosa, Escherichia coli, Pasteurella species and Brucella species (see Table 1.2) 
(Whelton and Nue, 1982).  
Neomycin has the ability to target Gram-negative bacteria and also exhibits activity against 
Gram-positive bacteria. It is usually used orally before gastrointestinal surgery and to reduce 
the risk of infection after intestinal surgeries. Neomycin B is found in ointments and used 
topically to treat bacterial skin diseases (Heidary and Cohen, 2005; Joint Formulary 
Committee, 2018).  
Gentamicin (11) is the aminoglycoside of choice in the United Kingdom (UK) (Joint 
Formulary Committee, 2018). It has activity against many Gram-negative bacteria (see Table 
1.2) (Whelton and Nue, 1982). It has its lowest minimum inhibitory concentration (MIC) 
against Staphylococcus epidermidis (MIC = 0.19), while its highest MIC is against 
Pseudomonas aeruginosa (Lebeaux et al., 2015). Gentamicin (11) is also effective in the 
treatment of pneumonia and urinary tract infections (UTIs) (Foye et al., 2008; Balakumar et 
al., 2010; Armstrong et al., 2012). 
Amikacin (9) is another aminoglycoside which exhibits a spectrum of activity against many 
organisms. It is effective against Pseudomonas aeruginosa, Escherichia coli, Shigella sp., 
Salmonella sp. and E. cloacae, as illustrated in Table 1.2 (Whelton and Nue, 1982). Amikacin 
(9) is used in the treatment for some strains of Mycobacterium tuberculosis and Yersinia 
tularensis infections that are resistant to other aminoglycosides (Joint Formulary Committee, 
2018). Amikacin (9) has the highest MIC against Pseudomonas and has the lowest MIC 
against Klebsiella pneumonia (Balakumar et al., 2010; Armstrong et al., 2012). 
Tobramycin (5) is one of the new aminoglycosides with new and improved activity. It is 
also a broad-spectrum antibiotic. Tobramycin (5) is more effective against Pseudomonas 
aeruginosa and is even more efficacious in the treatment of strains, which are resistant to 
gentamicin (11), as shown in Table 1.2 (Whelton and Nue, 1982). However, tobramycin (5) is 
not efficacious against gentamicin-resistant Enterobacteriaceae (LoBue, 2005; Zeitler et al., 
2012; Joint Formulary Committee, 2018). A tobramycin (5) plus carbenicillin combination 
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therapy is effective in the treatment of endocarditis caused by Pseudomonas which shows 
resistance to gentamicin (11) plus carbenicillin (Herzog et al., 2012). The most common or 
frequently prescribed aminoglycosides in the Kingdom of Saudi Arabia (KSA) are tobramycin 
(5), amikacin (9), and gentamicin (11) (Asghar and Ahmad, 2018). 
Kanamycin (6) has been used in the treatment of bacterial infectious for more than 60 years 
(Zhang et al., 2008). Kanamycin (6) has an efficacy against Enterobacter and Pseudomonas 
species, as indicated in Table 1.2 (Whelton and Nue, 1982; Bera et al., 2010; Ahmad and 
Mokaddas, 2014). Paromomycin (4) is efficacious against Cryptosporidium, Entamoeba and 
Giardia. Paromomycin (4) is used to treat different kinds of infections such as, giardiasis and 
amebiasis. Paromomycin (4) is the first line therapy for giardiasis and amebiasis during the 
pregnancy (Beale et al., 2010). Netilmicin (7) and sisomicin (8) have the same activity as 
tobramycin (5) and amikacin (9) (Beale et al., 2010). 
 
Table 1.2 Vulnerability of some strains of bacteria to some of aminoglycosides at 
Massachusetts General Hospital from the 1st of January to 25th of December in 1978 (Whelton 


















5 % 81 % 81 % 96 % 4 % 
Proteus 
mirabilis 
87 % 97 % 97 % 98 % 92 % 
Escherichia 
coli 
64 % 98 % 98 % 98 % 85 % 
Shigella sp. 33 % 100 % 100 % 100 % 96 % 
Salmonella sp. 52 % 100 % 98 % 98 % 98 % 
Klebsiella 
pneumoniae 




The Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee 
(ADAC) has recently (May 2018) voted in favour of plazomicin (Achaogen) for the treatment 
of adults with complicated urinary tract infections (cUTI) due to MDR Enterobacteriaceae 
including carbapenem-resistant Enterobacteriaceae (CRE), e.g. Klebsiella pneumoniae 
carbapenemase (KPC), New Delhi metallo--lactamase (NDM) (FDA, 2018). 
 
1.1.5. Chemistry and Structure-Activity Relationship (SAR) of Aminoglycosides 
 
Aminoglycosides can be divided into multiple subtypes and classes depending on their 
arrangement and synthesis. Aminoglycosides contain a 1,3-diaminoinositol moiety composed 
of either 2 deoxystreptamine ring (1), as in neamine (2), neomycin (3), paromomycin (4), 
tobramycin (5), kanamycin (6), netilmicin (7), sisomicin (8), and amikacin (9) or a streptidine 
ring, as in streptomycin (10) linked to inositol derivatives, such as L-neosamine, D-neosamine, 
purpurosamine, garosamine, D-ribose, and nebrosamine by glycosidic bonds. In fact, the name 
aminoglycoside inspired from its structure of aminosugars linked by glycosidic bonds (see 
Fig. 1.1, 1.2, and 1.3) (Maviglia  etal., 2009; Beale et al., 2010; Avent et al., 2011; Rahim et 
al., 2011; Hooper, 1982). 
Amino groups on the D-neosamine ring in neomycin (3), nebrosamine in tobramycin (5), 
purpurosamine in netilmicin (7) and sisomicin (8) are important for the antibacterial activity 
(see Fig. 1.1 and 1.2) (Benveniste and Davies, 2016). The main culprit in the development of 
resistance to these aminoglycosides was related to aminoglycoside-modifying enzymes 
(AMEs) that are produced by bacteria. These enzymes are associated with changes in the −OH 
or −NH2 groups on aminoglycosides, catalysed by enzymes such as N-acetyltransferase 
(NAT), O-adenyl transferase (OAT) and O-phosphoryl transferase (OPT), as shown in Fig. 
1.5 (Mingeot-Leclercq et al., 1999: Kling et al., 2007; Foye et al., 2008; Beale et al., 2010; 
Houghton et al., 2010). Amino groups at positions 2' and 6' of neomycin C (3), paromomycin 
(4), and sisomicin (8) are crucial for antibacterial activity (Beale et al., 2010). Some chemical 
changes on 2-deoxystreptamine’s functional groups are possible without any loss of 
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antibacterial activity. For example, amikacin (9) results from the acetylation of the N-1 of 
kanamycin (Fig. 1.6). 
 
Fig. 1.5 The modifications of bacterial enzymes on tobramycin 
 
 
Fig. 1.6 Amikacin results from acetylation of the N-1 of kanamycin 
 
Tobramycin (5) is one of the broad-spectrum aminoglycosides. One of its analogues is the 
6′′-thioether. This analogue is amphiphilic and has activity against tobramycin-resistant 
bacteria, as it is less prone to be activated by bacterial aminoglycoside-modifying enzymes. 
The lipophilic group of this analogue is effective due to its potency against bacteria and 
selective nature towards the bacterial membranes (Herzog et al., 2012). 
The addition of 4', 6'-O-acetal and 4'-O-ether on the 2-amino-2-deoxy-D-D-glucose ring of 
paromomycin (4) has the ability to enhance the selectivity of paromomycin, allowing it to 
target only the bacterial ribosome (Perez-Fernandez et al., 2014). 
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1.1.6. Side Effects of Aminoglycosides 
 
Aminoglycosides are drugs that are notorious for their side effects, which are associated 
with kidneys and hearing systems. The mechanisms of ototoxicity and nephrotoxicity of 
aminoglycoside antibiotics are incompletely understood. There are certain factors which are 
associated with the development of toxicity or side effects in patients taking aminoglycosides, 
including genetic pre-disposition, use of concomitant drugs, pre-existing disease and severity 
of illness. Prolonged use of aminoglycosides is also associated with toxicity (Avent et al., 
2011).  
The ototoxicity of aminoglycosides is divided into two types, namely vestibular toxicity 
and cochlear toxicity. The ototoxicity of these antibiotics is associated with their ability to 
penetrate the inner ear via the bloodstream where it then affects the cochlea or the vestibular 
system (Foye et al., 2008; Avent et al., 2011; Armstrong et al., 2012). One possible mechanism 
for ototoxicity is that aminoglycosides cause the modulation of the N-methyl-D-aspartate 
receptors (NMDAR) a subtype of L-Glutamate receptors (GluR). Glutamate is an important 
neurotransmitter in both the hair cells and the inner ear. Excessive glutamate has been linked 
with CNS toxicity and ear toxicity. Moreover, aminoglycosides are possibly related to high 
levels of nitric oxide that causes a release of free radicals. These free radicals are associated 
with damage to the proteins and other targets of the outer hair cells (OHCs) of the cochlea and 
the supporting cells of the basal region of the cochlea (Ricci, 2008; Armstrong et al., 2012; 
Petersen and Rogers, 2015). Ototoxicity developed through the use of aminoglycosides is 
irreversible (Selimoglu, 2007; Armstrong et al., 2012; Petersen and Rogers, 2015). 
Aminoglycoside antibiotics are nephrotoxic agents (Mingeot-Leclercq and Tulkens, 1999; 
Armstrong et al., 2012; Brenner and Stevens, 2013). They are excreted by the kidneys via 
glomerular filtration, and they might have a tendency to accumulate in the kidney cortex. This 
leads to a decline in the lysosomal phospholipase activity causing aminoglycoside-induced 
nephrotoxicity. The increase in number and size of lysosomes have been found with decreased 
lysosome stability. Another possible mechanism for nephrotoxicity is that aminoglycosides 
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may cause ultrastructural damage to the tubular epithelium or to the endothelium of the 
glomerular capillaries, however, this toxicity can be reversed with good hydration (Cojocel 
and Hook, 1983; Janknegt, 1990; Houghton et al., 2010; Armstrong et al., 2012). 
One of the lesser toxicities caused by aminoglycosides is neuromuscular toxicity. It is 
related to blockade caused by the aminoglycosides at the synaptic level. This neurotoxicity is 
associated with the use of certain drugs that block the neuromuscular junction (NMJ) whereby 
the presence of pre-existing illness combines to worsen the condition, such as myasthenia 
gravis (Burton, 2006; Avent et al., 2011). 
As a standard precaution, it is necessary for patients receiving aminoglycosides to be given 
notice regarding their toxicity. They should be able to identify and report any incidence of 
tinnitus, change in hearing, hearing loss, and vertigo (Burton, 2006; Avent et al., 2011). 
Monitoring the toxicity is also an important aspect in the treatment with aminoglycosides. 
There are no standards that could aid in the prevention, diagnosis, and treatment of toxicity, 
but certain tests should be carried out as a precaution. These can include quantitative testing 
of end-organ results (monitoring serum creatinine and audiometry) (Burton, 2006; Houghton 
et al., 2010). 
The use of aminoglycosides has decreased due to their side effects and the controversial 
debate regarding their mechanisms of toxicity. In order to understand their mechanisms of 
toxicity, one of the ultimate objectives is to be able to trace these natural compounds in the 
body in a non-invasive way by tagging them with a fluorescent probe. The use of fluorescent 
derivatives of aminoglycosides may provide an insight to understand their mechanisms of 
toxicity. However, random FITC-labelling may present some obstacles in which it can prevent 
the effectiveness of aminoglycosides by blocking their biological activity. Therefore, this 
study aims to investigate the specific or selective reactions of different amines located around 
tobramycin using FITC, depending on very important factors in medicinal chemistry, which 




1.2. Ionisation Constant 
 
1.2.1. General Introduction to Ionisation Constant (pKa) 
 
Ionisation constants (pKa of conjugate acid) are among the most frequently studied 
parameters and give considerable information about the physical and kinetic behaviour of 
chemical substances. pKa is defined as the pH at which functional groups, such as amino 
groups and carboxylic groups, exist as 50% ionized and 50% un-ionized. The first concept of 
the dissociation constant comes from the law of mass action, provided by Guldberg and Waage 
(1864). The concept was further strengthened by the works of Henderson and Hasselbalch 
(Henderson, 1908; Hasselbalch, 1916). pKa is expressed as the following: 
pKa = - log Ka 
In this equation, Ka is dissociation constant of the reaction. The dissociation of an acid in a 
solvent, such as water, is a reversible process proceeding in both forwards and backwards 
directions; the more dissociation, the stronger an acid is. The extent of the dissociation is 
measured in terms of Ka (Henderson, 1908; Hasselbalch, 1916; Po and Senozan, 2001; De 
Levie, 2003). 
Ka = [H3O+] [A−] / [HA] 
Ka is the ratio of dissociated and un-dissociated acid in a solution and thus measures the 
strength of an acid in a solution. The higher Ka, the stronger the acid is because of the higher 
dissociation, in other words, the lower the pKa, the stronger an acid, as shown in Fig. 1.7 
(Albert and Serjeant, 1984). The main advantage of using pKa instead of Ka is convenience. 
Due to the use of a logarithmic scale, a very large range of concentrations is covered in a 
convenient way. Use of this scale also has the advantage of converting very small values into 
















Fig. 1.7 The lower the pKa, the stronger an acid, the higher the pKa, the weaker an acid. 
 
Although the ionisation constants are considered to be constant, they are affected by some 
factors. The ionisation constants differ with changes in the length of the alkyl chain between 
two functional groups. One reason for this change is the inductive effect. When the distance 
between two functional groups increases the inductive effect decreases and vice versa (see Fig. 
1.8). The steric and resonance effects might decrease the pKa values of the functional groups, 
as shown in Fig. 1.8 (Takeda et al., 1983; Albert and Sargeant, 1984; Blagbrough et al., 2011). 
Takeda et al., (1983) used 15N NMR spectroscopy to determine the pKa values of spermidine. 
Examples for presenting ionisation constants of each ionisable group are cadaverine (1.5-
diaminopentane) and the closely related amino acid lysine. There are two ionisable groups in 
cadaverine, namely the two primary amines (NH2), whereas there are three ionisable groups 
in lysine, namely the carboxylic acid and the two similarly spaces amines groups. The pKa 
values of each ionisable group and the balanced net ionic equations for both compounds are 







Fig. 1.8 The increases of the alkyl chain distance lead to an increase in the pKa values of 
amines, the steric and resonance effects might decrease the pKa values of the amino groups in 











Fig. 1.9 The balanced net ionic equations of cadaverine (A) and L-S-lysine (B) for the reaction 
corresponding to each pKa in H2O 
 
 
Measuring the ionisation constants of any medication is significant in a variety of fields, 
such as food science, organic chemistry, analytical chemistry, drug development, and drug 
discovery (Bezençon et al., 2014). The importance of the knowledge of the dissociation 
constants of drugs and other substances is considered high in pharmaceutical systems as it 
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yields valuable information. Such information is important mainly because many drugs are 
either weak acids or weak bases. The knowledge of the ionisation constants gives information 
about the ionic properties of the drugs when exposed to a variety of pH range inside the body. 
When a drug is released from an orally ingested medicine, it is first exposed to the extremely 
acidic pH of the stomach and then the basic pH along the intestines. For drugs that are ionized 
at the physiological pH of the digestive system, there exists a requirement of specific 
transporters for the transportation across the epithelium of the digestive-(gastro-intestinal) 
tract. The drugs that are unionized can be absorbed by simple passive diffusion. Similarly, 
when absorbed into the bloodstream, drugs are exposed to an almost neutral or slightly basic 
pH of 7.4. Consequently, their ionization may restrict their crossing through the blood-brain 
barrier (BBB) (Hörter and Dressman, 2001). 
In terms of medicinal chemistry, detailed knowledge of the dissociation constants might 
provide hints helpful to design a new derivative of a drug which could be more effective or 
less toxic. Regarding aminoglycosides, studying the pKa values of amines on these alkaloids 
will afford a better understanding of their structure-activity relationships (SAR), especially the 
order in which these similar functional groups gain/lose protons. Such data may potentially 
help in understanding the order of target mRNA binding of key basic functional groups (Hörter 
and Dressman, 2001; Krężel et al., 2004; Manallack, 2007). Moreover, the specific or selective 
reactions of different amines located around aminoglycosides, e.g. with FITC, depending on 
steric effects and the ionisation constants of these amines, may provide an insight into 
understanding their distribution in the body and mechanisms of toxicity. 
 
1.2.2. Methods for measuring ionisation constants 
 
A number of techniques have been devised for measuring pKa, including potentiometry, 
ultraviolet (UV) spectroscopy, and nuclear magnetic resonance (NMR) spectroscopy. All these 
methods have their own principles, uses and limitations. Their principles, advantages and 
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limitations are introduced below (Albert and Serjeant, 1984; Box et al., 2008; Blagbrough et 
al., 2011; Reijenga et al., 2013). 
1.2.2.1. Potentiometry 
 
Although it is one of the most convenient ways to measure pKa as well as the required 
purity of the sample, a large sample size is needed compared to NMR spectroscopy technique. 
In the beginning, it was difficult to obtain the correct measurement of pH from the sigmoidal 
curve, but the process has been automated and software has been developed to reduce this 
particular type of error. Moreover, where a molecule contains multiple functional groups of a 
similar type, potentiometric titration cannot identify unambiguously the site of protonation. 
Therefore, it is not recommended to be used for measuring the ionisation constants of 
functional groups in complex compounds, such as aminoglycosides. Apart from all the 
difficulties and disadvantages, the simplicity and low cost of the potentiometric titration 
method of measuring dissociation constants mean that it has remained one of the most common 
methods for structurally relatively simple substances that are available in a pure form, in large 
amounts (Box et al., 2008; Reijenga et al., 2013). 
 
1.2.2.2. Ultraviolet-Visible (UV-Vis) spectroscopy 
 
A change in acidity leads to a change of colour in natural substances, which contain a 
chromophore. The ionisation of the molecule leads to a change in the spectrum of dissociated 
and non-dissociated molecules. This principle is employed in the UV-Vis spectrometer to 
measure the pKa of substances. Initially, visible light was used to measure the pKa of acid/base 
indicators; the technique was extended to be applied to other substances by using UV light 
(Box et al., 2008; Reijenga et al., 2013). The absorption is measured using two wavelengths 
across a pH range, where the second wavelength is used to provide line of reference. The ratio 
of absorption at the two wavelengths is plotted against the pH of the solution. The plot is in 
the form of a sigmoid curve and the pKa of the functional group can be estimated from the 
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inflexion point. This method was first developed by Holmes and Snyder, (1925). The method 
holds the advantage of being fast, has a good accuracy and can be automated to reduce errors. 
However, the UV spectrophotometric pH titration method cannot provide the site of 
protonation where the molecule contains several similar functional groups. Therefore, it 
cannot be used for measuring the ionisation constants of specific functional groups, which 
contain several such functional groups compounds (Box et al., 2008; Reijenga et al., 2013). 
Moreover, this method cannot be used for measuring the ionisation constants of substances 
lacking visible or UV chromophores, such as aminoglycoside antibiotics. Thus, there are no 
obvious published data about measuring the ionisation constants of aminoglycoside antibiotics 
(Blagbrough et al., 2011). 
 
1.2.2.3. Nuclear Magnetic Resonance (NMR) spectroscopy 
 
NMR spectroscopy is another way to measure pKa. It is based on the principle that some 
nuclei have a charge and a spin. The NMR chemical shifts of a compound depend upon their 
magnetic and therefore chemical environment. Consequently, gradual change of the acidity or 
basicity leads to alterations in their chemical shifts () (see Fig. 1.10). This phenomenon is 
sometimes used to determine the ionisation constants. These chemical shifts are plotted against 
the pH; the pKa values can be extracted from the inflection points of the sigmoidal curves. The 
technique was first reported by Grunwald to determine the pKa of amines in 1957 (Grunwald 
et al., 1957; Frassineti et al., 1995; Fărcaşiu et al., 1996; Gift  et al., 2012; Reijenga et al., 
2013; Bezençon et al., 2014). 
The main advantage of using NMR spectroscopy over potentiometry or the UV 
spectroscopy method, where there is a suitable chromophore, is that NMR spectroscopy is a 
powerful technique when it comes to separating and measuring distinct ionisation constants of 
functional groups within complex compounds, such as aminoglycoside antibiotics, which have 
more than one ionisable group (Blagbrough et al., 2011; Reijenga et al., 2013). Therefore, 
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NMR spectroscopy was used in this research project in order to measure the pKa values of 
amines in selected aminoglycosides. 
 
Fig. 1.10 1H chemical shifts of paracetamol at different pH values in D2O, the pKa value of the 
phenol/phenoxide is extracted from the inflection point of the sigmoidal curves, which is 10.50 
(taken from Bezençon et al., 2014). 
 
1.3. Aims and Objectives 
 
The pharmaceutical analysis and medicinal chemistry of a series of aminoglycoside 
antibiotics consisting of neomycin C (3), paromomycin (4), tobramycin (5), kanamycin B (6), 
netilmicin (7), sisomicin (8), amikacin (9), and streptomycin (10) will be investigated in this 
full-time MPhil. In these investigations, we will: 
A. Obtain the literature pKa data of these aminoglycosides and have a focus on the 
specificity of their assignment, together with the accuracy of their assignments using 
potentiometry and different NMR nuclei:  1H, 13C, and 15N. 
B.  Measure the individual pKa values using combinations of 1H, 13C, and 15N HMBC NMR 
spectroscopic data, in order to separate the many and varied ionisation constants. 
C. Investigate a few specific or selective reactions of different amines located around 
tobramycin with amino acid protecting groups and with fluorophores. These are 
preliminary synthetic studies with a view to the synthesis of biologically relevant 





Literature Review of the pKa Values of Amino Groups on Aminoglycoside Antibiotics 
Measured using Potentiometry and NMR Spectroscopy 
 
Examples of all published measurements of the pKa values of the amino groups on 2-
deoxystreptamine (1), neamine (2), neomycin (3), paromomycin (4), tobramycin (5), 
kanamycin A and B (6), sisomicin (8), amikacin (9), streptomycin (10), gentamicin C1, C1a, 
and C2 (11) using potentiometry and NMR spectroscopy are presented in sections 2.1 to 2.10. 
In the literature, all potentiometric titrations were performed using a pH meter fitted with 
a glass electrode and another electrode as an indicator. The majority of the measurements were 
fully automated under the control of different kinds of software, such as Matlab 6.5.1 or 
HYPERQUAD. All potentiometric experiments were carried out at  25°C (unless otherwise 
indicated) in aqueous solutions at different concentrations as indicated some equivalents of 
HCl were added to produce a completely protonated form of the antibiotic at the start of 
titration. Then, the solution was titrated with aqueous NaOH using an autotitrator.  
NMR spectroscopy is another way to measure pKa values. Generally, the ionisation 
constants were measured using variations in the chemical shift () with 1H, 13C, and 15N HMBC 
NMR spectroscopies. The chemical shifts were then plotted against the pH, and the pKa values 
are extracted from the inflection points of the sigmoidal curves. In the literature, the pKa values 
of some aminoglycosides, neomycin (3), paromomycin (4), tobramycin (5), amikacin (9), 
gentamicin C1, C1a, and C2 (11), were measured using 1D 15N NMR spectroscopy. The 1D 
l5N measurements were carried out using 15 mm sample tubes that contained concentrated 
solutions of the aminoglycosides, using uniformly enriched 15N-aminoglycosides, which was 
prepared from cultures of Streptomyces or Micromonospora grown in 15N-enriched media, or 
by increasing the length of time of the acquisition i.e. increasing number of scans. All NMR 
measurements were carried out referenced relative to HDO, DSS, or TSP signals for 1H and 
13C NMR spectroscopy and 15NH4Cl, NH3, or NH415NO3 for 15N NMR spectroscopy in either 
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D2O or different ratios of H2O/D2O at  25°C (unless otherwise indicated). The main advantage 
of using NMR spectroscopy is that it is a powerful technique when it comes to separating and 
measuring distinct ionisation constants of functional groups within aminoglycosides. 
There are no published data about measuring the ionisation constants of aminoglycoside 
antibiotics using UV-Vis spectrophotometry, because the analytes lack visible or even UV 
chromophores in their structures. However, there is one paper published by Fuentes et al., 
(2014) about measuring the pKa value of N-2' on different hydrazine derivatives of the 
aldehyde functional groups of streptomycin using UV-Vis spectrophotometry (see section 
2.10). 
 
2.1. 2-Deoxystreptamine (1) 
 
                       Individual pKa values 
Method 
pKa 1 pKa 2 
Potentiometry a 8.95 7.14 
Potentiometry b 9.12 7.45 
 
a pKa values of amines of 0.01 M 2-deoxystreptamine (1) determined using potentiometry in H2O at 
25℃ (Inouye, 1968) 
b pKa values of amines of 0.10 M 2-deoxystreptamine (1) determined using potentiometry in H2O at 










2.2. Neamine (2) 
 
 
                     Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 
Potentiometry a not reported 8.62 7.73 6.35 
Potentiometry b 9.43 8.62 7.73 6.35 
Potentiometry c 9.23 8.31 6.98 6.00  
 
a pKa values of amines of 0.001 M neamine (2) determined using potentiometry in H2O at 25℃ (Sutrisno 
et al., 2001) 
b pKa values of amines of 0.10 M neamine (2) determined using potentiometry in H2O at 25℃ (Baran 
et al., 2001) 
c pKa values of amines of 0.10 M neamine (2) determined using potentiometry in H2O at 25℃ (Tiwow, 
2014)  
 
                Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-6' 
1H NMR a 7.77  6.44  7.23  8.08  
 
a pKa values of individual nitrogen atoms of 0.01 M neamine (2) determined using 1H NMR spectroscopy 











              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 pKa 5 pKa 6 
Potentiometry a 9.72 9.24 8.61 8.05 7.55 6.30 
Potentiometry b 9.37 8.74 8.14 7.60 7.20 5.69 
Potentiometry c 8.78 8.43 8.18 7.64 7.05 5.69 
 
a pKa values of amines of 0.01 M neomycin (3) determined using potentiometry in H2O at 25℃ (Baran 
et al., 2001) 
b pKa values of amines of 0.15 M neomycin (3) determined using potentiometry in H2O at 23℃ 
(Jeżowska et al., 2005) 











             Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-6' N-2''' N-6''' 
15N NMR a 8.04 5.74 7.55 8.60 7.60 8.80 
15N NMR b 8.70 6.90 8.30 9.20 8.30 9.50 
15N NMR c 7.90 5.70 7.40 8.10 7.70 8.70 
1H NMR d 8.10 5.40 7.60 8.70 7.50 8.80 
 
a pKa values of individual nitrogen atoms of 0.10 M neomycin (3) determined using 15N NMR 
spectroscopy in H2O/D2O (85: 15 v/v) relative to NH415NO3 at 25℃ (Botto and Coxon, 1982) 
b pKa values of individual nitrogen atoms of 0.45 M neomycin (3) determined using 15N NMR 
spectroscopy in H2O/D2O (90:10 v/v)  relative to NH3 by using 1.0 M 15N urea in DMSO at 25℃ (Kaul 
et al., 2003) 
c pKa values of individual nitrogen atoms of 0.001 M 15N-neomycin (3) determined using 15N NMR 
spectroscopy in H2O/D2O (90: 10 v/v) relative to 15NH4Cl at 25℃ (Özen et al., 2006) 
d pKa values of individual nitrogen atoms of 0.01 M neomycin (3) determined using 1H-13C HSQC NMR 

















2.4. Paromomycin (4) 
 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 pKa 5 
Potentiometry a 8.90 8.23 7.57 7.05 5.99 
 
a pKa values of amines of 0.15 M paromomycin (4) determined using potentiometry in H2O at 37℃ 
(Avdeef, 2012) 
 
             Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-2''' N-6''' 
15N NMR a 8.65  7.07  8.33  8.25  9.46  
15N NMR b 8.20  6.50  8.07  7.91  9.13  
 
a pKa values of individual nitrogen atoms of 0.45 M paromomycin (4) determined using 15N NMR 
spectroscopy in H2O/D2O (85: 15 v/v)  relative to NH3 using 1 M [15N] urea in DMSO at 25℃ (Kaul et 
al., 2003) 
b pKa values of individual nitrogen atoms of 0.01 M paromomycin (4) determined using 15N NMR 
spectroscopy in H2O/D2O (85: 15 v/v) relative to NH3 using 1 M [15N] urea in DMSO at 25℃ (Barbieri 






2.5. Tobramycin (5) 
 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 pKa 5 
Potentiometry a 9.00 8.38 7.71 7.10 6.10 
 
a pKa values of amines of 0.10 M tobramycin (5) determined using potentiometry in H2O at 25℃ 
(Jeżowska et al., 1998) 
 
             Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 
15N NMR a 7.40 6.20 7.60 8.60 7.40 
1H NMR b 7.30 6.60 7.50 8.40 7.30 
15N NMR c 7.40 6.40 7.70 8.50 7.40 
 
a pKa values of individual nitrogen atoms of 0.15 M tobramycin (5) determined using 15N NMR 
spectroscopy in H2O/D2O (90: 10 v/v) relative to 15NH4Cl at 25℃ (Dorman et al., 1976) 
b pKa values of individual nitrogen atoms of 0.10 M tobramycin (5) determined using 1H NMR 
spectroscopy in D2O relative to TMS at 25℃ (Pagano et al., 2011) 
c pKa values of individual nitrogen atoms of 0.80 M tobramycin (5) determined using 15N NMR 







2.6. Kanamycin A and B (6) 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 pKa 5 
Potentiometry a 9.12 8.25 7.60 6.91 5.74 
Potentiometry b 9.03 8.16 7.42 6.19 - 
Potentiometry c 9.16 8.27 7.52 6.28 - 
 
a pKa values of amines of 0.10 M kanamycin B (6) determined using potentiometry in H2O at 25℃ 
(Jeżowska et al., 1998) 
b pKa values of amines of 0.001 M kanamycin A (6) determined using potentiometry in H2O at 25℃ 
(Szczepanik et al., 2002) 
c pKa values of amines of 0.003 M kanamycin A (6) determined using potentiometry in H2O at 23℃ 
(Fuentes et al., 2010a) 
 
             Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-6' N-3'' 
1H NMR a 8.12 6.04 9.03 7.46 
a pKa values of individual nitrogen atoms of 0.01 M kanamycin A (6) determined using 1H NMR 






2.7. Amikacin (9) 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 
Potentiometry a 9.90 8.89 7.81 6.83 
Potentiometry b 9.78 8.91 7.78 6.88 
Potentiometry c 9.49 8.77 7.84 7.34 
a pKa values of amines of 0.10 M amikacin (9) determined using potentiometry in H2O at 25℃ 
(Jeżowska and Bal, 1998) 
b pKa values of amines of 0.06 M amikacin (9) determined using potentiometry in H2O at 25℃ (Fuentes 
et al., 2010b) 
c pKa values of amines of 0.001 M amikacin (9) determined using potentiometry in H2O at 25℃ 
(Alekseev and Markova, 2016) 
 
         Individual nitrogen atoms pKa 
Method 
N-3 N-6' N-3'' N-4''' 
13C NMR a 7.40 9.50 8.50 10.10 
15N NMR b 7.62  8.92  8.13  9.70  
a pKa values of individual nitrogen atoms of 0.1 M amikacin (9) determined using 13C NMR 
spectroscopy in H2O relative to TSP at 25°C (Gaggelli et al., 1995) 
b pKa values of individual nitrogen atoms of 0.8 M amikacin (9) determined using 15N NMR 






2.8. Sisomicin (8) 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 pKa 5 
Potentiometry a 9.41 8.65 7.98 7.25 6.08 
 
a pKa values of amines of 0.10 M sisomicin (8) determined using potentiometry in H2O at 25℃ (Krężel 
et al., 2004) 
             Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 
1H NMR a 7.34 6.11 7.93 9.45 8.63 
 
a pKa values values of individual nitrogen atoms of 0.01 M sisomicin (8) determined using 1H NMR 












2.9. Gentamicin C1, C1a, and C2 (11) 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 pKa 4 pKa 5 
Potentiometry a 9.86 8.81 8.12 7.31 5.68 
Potentiometry b 9.49 8.86 8.18 7.38 5.76 
Potentiometry c 9.59 8.79 8.21 7.42 5.83 
 
a pKa values of amines of 0.01 M gentamicin C1 (11) determined using potentiometry in H2O at 25℃ 
(Lesniak et al., 2003) 
b pKa values of amines of 0.01 M gentamicin C1a (11) determined using potentiometry in H2O at 25℃ 
(Lesniak et al., 2003) 
c pKa values of amines of 0.01 M gentamicin C2 (11) determined using potentiometry in H2O at 25℃ 









            Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 
1H NMR a 7.67  6.19  7.40  9.86  8.78  
15N NMR b 8.91  7.22  8.17  9.99  9.25  
 
a pKa values of individual nitrogen atoms of 0.001 M gentamicin C-1 determined using 1H NMR 
spectroscopy in 99.9% D2O relative to TSP at 25°C (Lesniak et al., 2003) 
b pKa values of individual nitrogen atoms of 0.8 M gentamicin C (mixture) determined using 15N NMR 
spectroscopy in H2O/D2O (85: 15 v/v) relative to 15NH4Cl at 25°C (Lesniak et al., 2003) 
 
2.10. Streptomycin (10) 
 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 
Potentiometry a 7.66 not reported not reported 
Potentiometry b 7.94 not reported not reported 
Potentiometry c 7.91 not reported not reported 
 
a pKa values of amines of streptomycin (10) HCl determined using potentiometry (Kuehl et al., 1946) 
b pKa values of amines of 0.02 M streptomycin (10) determined using potentiometry in H2O at 25℃ 
(Fuentes et al., 2010b) 
c pKa values of amines of 0.008 M streptomycin (10) determined using potentiometry in H2O at 25℃ 




             Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' 
1H NMR a 13.55  12.33  8.29  
 
a pKa values of individual nitrogen atoms of 0.001 M streptomycin (10) determined using 1H NMR 
spectroscopy in H2O/D2O (95: 05 v/v) relative to DSS at 25°C (Orgován and Noszál, 2012) 
 
              Individual pKa values 
Method 
pKa 1 pKa 2 pKa 3 
UV-Vis a 7.48 not reported not reported 
 
a pKa values of amines of hydrazine derivatives of streptomycin (10) determined using UV-Vis 
spectrophotometry (Fuentes et al., 2014) 
In conclusion, although potentiometry is one of the most convenient and automated 
methods to measure pKa values, potentiometric titration cannot identify unambiguously the 
site of protonation. It can be easily seen that the pKa values of some amines on some 
aminoglycoside antibiotics obtained using potentiometry are inconsistent. For example, the 
pKa values of six amines of neomycin reported by Baran et al., (2001) are 9.37, 8.74, 8.14, 
7.60, 7.20, and 5.69, However, the pKa values of the same amines on the same compound of  
neomycin reported by Avdeef et al., (2012) are 8.78, 8.43, 8.18, 7.64, 7.05, and 5.69 in the 
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same solvent (H2O), at 25℃. The difference in the concentration (0.01 M of neomycin 
reported by Baran et al., (2001) and 0.15 M of neomycin reported by Avdeef et al., (2012)) 
could explain the difrences in the pKa values reported. The variation observed in the pKa values 
could be due to the differences in the concentrations, temperatures, and NMR instruments. 
When the literature on the determination of pKa values of amines on aminoglycoside 
antibiotics is examined, it can be seen that there are some amines on some aminoglycosides 
not reported, such as an amine on neamine and the two guanidine groups on streptomycin. 
The main advantage of using NMR spectroscopy over potentiometry or the UV 
spectroscopy method is that NMR spectroscopy can identify unambiguously the site of 
protonation within complex compounds, such as aminoglycoside antibiotics. In the literature, 
the amines on some aminoglycosides, such as neomycin (3), paromomycin (4), tobramycin 
(5), amikacin (9), gentamicin C1, C1a, and C2 (11), were measured using 1D 15N NMR 
spectroscopy. However, it is not impossible but it is difficult to assign the individual nitrogen 
atoms on aminoglycosides using 1D 15N NMR spectroscopy. The assignments of individual 
nitrogen atoms on aminoglycosides using 1D 15N NMR spectroscopy have been discussed 
(Dorman et al., 1976; Botto and Coxon, 1982). There is only one published article (Gaggelli 
et al., 1995) for measuring the pKa values of amines on an aminoglycoside using 13C NMR 
spectroscopy. Those studies were on amikacin (9).  
In this thesis, the pKa values of  2-deoxystreptamine (1), neamine (2), neomycin C (3), 
paromomycin (4), tobramycin (5), kanamycin B (6), netilmicin (7), sisomicin (8), amikacin 
(9), and streptomycin (10) were measured using new combinations of 1H, 13C, and 15N HMBC 
NMR data, in order to separate the many and varied ionisation constants. Measuring the pKa 
values using 15N HMBC NMR spectroscopy has not been previously reported. The advantages 
of using 15N HMBC over 1D 15N NMR spectroscopy are that the assignment of individual 
nitrogen atoms on aminoglycosides using 15N HMBC spectroscopy is much easier than using 
1D 15N NMR spectroscopy. Moreover, the length of time required for the acquisition of 15N 








3.1. Materials and General Methods 
 
Deuterium oxide (D2O), CD3OD, CDCl3, DCl and NaOD were purchased from Goss 
Scientific. The purchased DCl was a 20% concentration solution in D2O. NaOD was a 30% 
concentration solution in D2O. Anhydrous methanol, ethyl acetate, dichloromethane (DCM), 
triethylamine (Et3N), dimethylformamide (DMF) and aqueous ammonia (32%) were 
purchased from VWR. Neamin free base (2) was purchased from Carbosynth. 2-
Deoxystrptamine (1), neomycin sulfate (3), paromomycin sulfate (4), tobramycin sulfate (5), 
kanamycin B sulfate (6), netilmicin sulfate (7), sisomicin sulfate (8), amikacin sulfate (9), 
streptomycin sulfate (10), potassium hydrogen phthalate, di-sodium tetra-borate, fluorescein 
isothiocyanate (FITC), ninhydrin, di-tert-butyl dicarbonate ((Boc)2O), N-
(benzyloxycarbonyloxy)-phthalimide(O-Cbz-N-hydroxyphthalimide) trimethylsilylpropanoic 
acid (TMSP), nitromethane (CH3NO2), sodium sulfate (Na2SO4), and potassium carbonate 
(K2CO3) were purchased from Sigma-Aldrich. 
Column chromatography has been performed over silica gel 60-120 mesh (purchased from 
Sigma-Aldrich) using different ratios of methanol, ethyl acetate, dichloromethane (DCM), 
aqueous ammonia (32%), and triethylamine (Et3N) as eluents. 
Thin-Layer Chromatography (TLC) over silica gel has been performed using aluminium-
backed sheets coated with Kieselgel 60 F254 purchased from Merck. Ninhydrin TLC spray 








NMR spectra including 1H, 13C, HSQC, HMBC, NOESY, and 15N HMBC were recorded 
on Bruker Avance III (operating at 500.13 MHz for 1H, 125.77 MHz for 13C, and 50.67 MHz 
for 15N HMBC) spectrometers at 25℃ (unless otherwise indicated). MestReNova and Bruker 
Topspin have been used for processing the spectra. 1H and 13C chemical shifts () were 
observed and are reported in parts per million (ppm) relative to trimethylsilylpropanoic acid 
(TMSP) at 0.00 ppm as an internal reference and 15N HMBC chemical shifts were measured 
relative to external nitromethane (CH3NO2 in CDCl3 (1:1, v/v) at -511.72 ppm (Wishart et al., 
1995). The total recording time differs for each isotope as follows:  less than 2 min, 30 min, 
and 60 min per data point for 1H, 13C, and 15N HMBC NMR spectroscopy, respectively. 
High Resolution Time-of Flight (HR TOF) mass spectra were obtained on a Bruker 
Daltonics “micrOTOF” mass spectrometer using electrospray ionisation (ESI) (loop injection 
+ve mode). 
 
3.3. Calibration of 5mm NMR tube-pH electrode 
 
A 5mm NMR tube-pH electrode purchased from Sigma-Aldrich, was used for measuring 
pH values. The electrode easily fitted into the 5mm NMR tube. Standard buffers consisting of 
0.40 M potassium hydrogen phthalate in H2O, pH 4.00 and 0.01 M di-sodium tetra-borate in 
H2O, pH 9.18 were used for calibrating the 5mm NMR tube-pH electrode. All the 
measurements were carried out at 25℃. 
 
3.4. pKa determination using 1H, 13C, and 15N HMBC NMR spectroscopy 
 
Aminoglycoside analyte solutions were prepared at ~10 mg/mL concentration. These 
solutions typically started at ~0.7 M analyte, beginning from an acidic pH and adjusting with 
0.5 M NaOD to pH = 14, when the final concentration will have been diluted to ~0.2 M. 
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Experiments were within the range 1.00-0.15 M aminoglycoside in 99.97% D2O and 100% 
H2O. The pH values were adjusted using 0.5 M NaOD and 0.5 M DCl (for measuring pKa in 
99.97% in D2O) and 0.5 M NaOH and 0.5 M HCl (for measuring pKa in 100% in H2O). 
MestReNova and Bruker Topspin were used for analysis of the recorded spectra. Chemical 
shifts of 1H, 13C, and 15N HMBC of aminoglycosides at varying pH values were plotted against 
pH values. The nonlinear sigmoidal curve and the inflection point of the sigmoidal curve were 
determined using GraphPad Prism 7 (Version 2017), after subtraction of 0.5 to convert the 
measured pD values into pH values (Popov et al., 2006). The pKa values of individual nitrogen 
atoms of aminoglycosides are extracted from the inflection points of the sigmoidal curves. 
 
3.5. Synthesis of compound 12 
 
This synthesis was carried out following the protocols in Michael et al. (1999) with 
modification such that tobramycin was used instead of neomycin and 5.0 equiv. was used 
instead of 6 equiv. A solution of tobramycin (5) (0.405 g, 0.866 mmol) in a mixture of DMF, 
water, and triethylamine (2: 1: 0.02 v/v/v) was treated with di-tert-butyldicarbonate (Boc)2O 
(0.945 g, 4.331 mmol, 5 equiv.). The reaction was maintained at 60℃ for 24h. The volatiles 
were removed in vacuo. The residue was partitioned between ethyl acetate and water (2:1 v/v). 
The aqueous layer was extracted with ethyl acetate (7 x 150 mL), dried (Na2SO4), and then 
concentrated under reduced pressure. The crude material was subject to column 
chromatography using dichloromethane (DCM) in methanol (95: 05 v/v). The desired product 
was obtained as a white solid (0.675 g, 80%). TLC analysis showed one spot (Rf = 0.5, ethyl 
acetate: aqueous ammonia, 95: 05 v/v).  
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HRMS: Found 990.5203, C43H77NaN5O19 requires 990.5102 [M + Na]+; 
IR: 2998 (NH) and 1688 (C=O) cm-1; 
1H NMR (500.13 MHz, CD3OD and CDCl3 (1: 1 v/v)): 1.36-1.50 (overlapping s, 45H, 15 x 
CH3, Boc), 1.49-1.61 (m, 1H, H-2ax), 1.62-1.69 (m, 1H, H-3'ax), 2.04-2.16 (m, 1H, H-3'eq), 
2.20-2.29 (m, 1H, H-2eq), 3.25-3.55 (m, 9H, H-1, H-4, H-6, H-2', H-4', H-6'a, H-6'b, H-4'',  
and H-5''), 3.68-3.86 (m, 6H, H-3, H-5, H-2'', H-3'', H-6''a, and H-6''b), 3.88-3.95 (m, 1H, H-
5'), 4.85-5.09 (m, 2H, H-1' and H-1''); 
13C NMR (125.77 MHz, CD3OD and CDCl3 (1: 1 v/v)): 30. 29 (15 x CH3, Boc) 35.06 (CH2-
3'), 35.98 (CH2-2), 43.32 (CH2-6'), 52.52 (CH-3), 52.60 (CH-1 and 2'), 58.24 (CH-3''), 63.68 
(CH2-6''), 67.59 (CH-4'), 71.34 (CH-4''), 73.57 (CH-5''), 75.16 (CH-2''), 76.14 (CH-5'), 78.23 
(CH-5), 81.80 (5 x Cq, Boc) 84.57 (CH-4), 85.84 (CH-6), 101.31 (CH-1' and 1''), 160.64 (5 x 
C=O, Boc). 
 
3.6. Synthesis of compound 13 
 
This synthesis was carried out following the protocols in Michael et al., (1999) with 
modification such that tobramycin was used instead of neomycin, 4.0 equiv. was used instead 
6 equiv., and 0℃ was used instead of 60℃. A solution of tobramycin (5) (0.403 g, 0.862 
mmol) in a mixture of DMF, water, and triethylamine (2: 1: 0.02 v/v/v) was treated with di-
tert-butyldicarbonate (Boc)2O (0.752 g, 3.447 mmol, 4.0 equiv.). The reaction was held at 0°C 
for 2h and then allowed to warm to 20 °C for a further 22h. The volatiles were removed in 
vacuo. The residue was partitioned between ethyl acetate and water (2:1 v/v). The aqueous 
layer was extracted with ethyl acetate (7 x 150 mL), dried (Na2SO4), and then concentrated 
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under reduced pressure. The crude material was subject to column chromatography using 
dichloromethane in methanol (90: 10 v/v). The desired product was obtained as a white solid 
(0.230 g, 31%). TLC analysis showed one spot (Rf = 0.4, ethyl acetate: ethanol: aqueous 
ammonia, 7: 2: 1 v/v/v).  
HRMS: Found 868.491, C38H70N5O17 requires 868.471 [M + H]+; 
1H NMR (500.13 MHz, CD3OD ): 1.26-1.39 (m, 1H, H-2ax), 1.38-1.49 (overlapping s, 36H, 
12 x CH3, Boc), 1.60-1.67 (m, 1H, H-3'ax), 2.02-2.17 (m, 2H, H-2eq and 3'eq), 2.73-62.88 (m, 
1H, H-3), 3.12-3.48 (m, 6H, H-4, H-4', H-6'a, H-6'b, H-4'', and H-5''), 3.47-3.81 (m, 8H, H-1, 
H-5, H-6, H-2', H-2'', H-3'', H-6''a, and H-6''b), 3.88-4.02 (m, 1H, H-5'), 4.93-5.01 (m, 1H, H-
1''), and 5.04-5.12 (m, 1H, H-1'); 
13C NMR (125.77 MHz, CD3OD): 30. 29 (12 x CH3, Boc), 34.84 (CH2-3'), 36.96 (CH2-2), 
42.98 (CH2-6'), 51.28 (CH-1), 52.12 (CH-3), 52.61 (CH-2'), 57.35 (CH-3''), 62.01 (CH2-6''), 
67.02 (CH-4'), 69.73 (CH-4''), 71.97 (CH-5''), 74.45 (CH-5'), 74.68 (CH-2''), 76.10 (CH-5), 
80.41 (4 x Cq, Boc), 84.82 (CH-6), 89.81 (CH-4), 99.50 (CH-1'), 100.97 (CH 1''), 158.08 (4 x 
C=O, Boc). 
 
3.7. Attempted synthesis of compound 14 
 
This synthesis was carried out following the protocols in Michael et al., (1999) with 
modification such that tobramycin was used instead of neomycin, 1.0 equiv. was used instead 
6 equiv., and 0℃ was used instead of 60℃. A solution of tobramycin (5) (0.502 g, 1.073 
mmol) in a mixture of DMF, water, and triethylamine (2: 1: 0.02 v/v/v) was treated with di-
tert-butyldicarbonate (Boc)2O (0.234 g, 1.073 mmol, 1.0 equiv.). The reaction was held at 0 
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°C for 2h and then warmed to 20 °C for a further 22h. TLC analysis showed the presence of 
several spots and one major spot which was the starting material (methanol: aqueous ammonia 
3:2 v/v). 
HRMS: showed several peaks (the desired compound 14 was not detected). 
1H and 13C NMR spectroscopy showed complicated spectra. 
 
3.8. Attempted synthesis of compound 15 
 
 
This synthesis was carried out following the protocols in Chandrika et al., (2015) except 
that 0℃ was used instead of 20℃. A solution of tobramycin (5) (0.078 g, 0.166 mmol) in a 
mixture of methanol, water (1:1 v/v), and K2CO3 (0.022 g, 0.166 mmol, 1 equiv.) was treated 
with N-(benzyloxycarbonyloxy) phthalimide (O-Cbz-N-hydroxyphthalimide) (0.049 g, 0.166 
mmol, 1.0 equiv.). The reaction was held at 0 °C for 2h and then warmed to 20 °C for a further 
22h, and then concentrated under reduced pressure. The desired compound 15 was detected 
using HRMS: found 624.288, C26H43NaN5O11 requires 624.301 [M + Na]+. However, 
purification by column chromatography using MeOH and a gradient of triethylamine (0-6%) 








3.9. Attempted synthesis of compound 16 
 
This synthesis was carried out following the protocols in Litovchick al., (2001) except that 
the compound 13 was used instead of neomycin (3). A solution of compound 13 (0.150 g, 
0.172 mmol) in a mixture of water/ methanol/ dioxane (1:1:1, v/v/v) was treated with FITC 
(0.135 g, 0.344 mmol, 2.0 equiv.). The reaction solution was maintained at 60°C for 24h. TLC 
analysis showed the presence of one major spot, the starting material (ethyl acetate: ethanol: 
aqueous ammonia, 7: 2: 1 v/v/v). 
HRMS: showed the peak of the starting material (compound 13) (the desired compound 16 
was not detected). 
1H and 13C NMR spectroscopy showed complicated spectra. 
Another attempt was carried out following the protocols in Bandyopadhyay et al., (2017) 
except that the reaction was heated at 80℃ for 27h rather than 20℃ for 1h. A solution of 
compound 13 (0.200 g, 0.230 mmol) in a mixture of DMF (2 mL) and Et3N (1 mL) was treated 
with FITC (0.179 g, 0.460 mmol, 2.0 equiv.). The reaction solution heated at 80°C for 72h. 
TLC analysis showed the presence of one major spot, the starting material (compound 13) 
(ethyl acetate: ethanol: aqueous ammonia, 7: 2: 1 v/v/v). 
HRMS: showed the peak of the starting material (compound 13) (the desired compound 16 





Results and Discussion 
 
 
Fig. 4.1 2-Deoxystreptamine (1), neamine (2), neomycin C (3), paromomycin (4), tobramycin 
(5), kanamycin B (6), netilmicin (7), sisomicin (8), amikacin (9), and streptomycin (10) 
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The individual ionisation constants, the pKa values of the individual amino groups of 2-
deoxystreptamine (1), neamine (2), neomycin C (3), paromomycin (4), tobramycin (5), 
kanamycin B (6), netilmicin (7), sisomicin (8), amikacin (9), and streptomycin (10) (see Fig. 
4.1) were determined using chemical shift () variation with 1H, 13C, and 15N HMBC NMR 
spectroscopy. The chemical shifts of 1H, 13C, and 15N of these (semi-synthetic and) natural 
products depend on their chemical environment. Consequently, the gradual change in acidity 
or basicity leads to subtle alterations in their chemical shifts () (see Fig. 4.2). 
The ionisation constants were measured for different kinds of amines on aminoglycoside 
alkaloids (see Table 4.1). Unambiguous assignments were made for each individual proton, 
carbon, and amine substituent on these clinically important aminoglycoside antibiotics using 
1H, 13C, HSQC, HMBC, NOESY, and 15N HMBC NMR spectroscopy (see Fig. 4.3) . Where 
proton and carbon signals overlap, 1H-13C HSQC was used to determine the chemical shifts 
() of each of the protons and the carbons. These chemical shifts were then plotted against the 
pH; the pKa values can be extracted from the inflection points of these sigmoidal curves. 
The reason for using NMR spectroscopy rather than potentiometry or UV 
spectrophotometry is that NMR spectroscopy is a powerful technique when it comes to 
separating and measuring distinct pKa values of amino groups located around aminoglycoside 
antibiotics. The NMR signals measured at low pH are diagnostic of the fully (>99%) 
protonated forms of these amino substituents. On the other hand, the signals obtained at high 
pH indicate the deprotonated amines on these alkaloids. The 1H and 15N peaks shift down-field 
with decreasing pH. The 1H and 15N NMR spectroscopic data show that each NH2 group 
resonated at lower chemical shifts () (ppm) than its the corresponding protonated amine 












Fig. 4.2 NMR spectra (in D2O) between pD 2.28 and 11.34 showing chemical shifts  (ppm) 
of:  A) (1H NMR) H-1/3, H-2ax, H-2eq, H-4/6, H-5 and B) (13C NMR) C-1/3, C-2, C-4/6, and 




Fig. 4.3 15N HMBC NMR spectrum of paromomycin in D2O at 25°C at pD 6.50  
 
Table 4.1 The number of amino groups (X) of particular aminoglycoside antibiotics 
Aminoglycoside X 1° 2° Side chain Guanidine R-CH2NH2 
2-deoxystreptamine 2 2 0 0 0 0 
neamine 4 4 0 0 0 1 
neomycin C 6 6 0 0 0 2 
paromomycin 5 5 0 0 0 1 
tobramycin 5 5 0 0 0 1 
kanamycin B 5 5 0 0 0 1 
amikacin 4 4 0 1 0 0 
sisomicin 5 4 1 0 0 1 
netilmicin 5 3 2 0 0 1 
streptomycin 3 0 1 0 2 0 
 
X. Number of amino groups 
1°. Primary amine 





4.1.  Determination of the pKa values of the individual amino groups on neomycin C (3) 
and tobramycin (5) using 1H NMR spectroscopy in H2O 
 
D2O (heavy water) is broadly used in chemistry as a solvent alternative to H2O. In terms of 
measuring pKa values, the comparisons of pH and pD determined data are not straightforward, 
because the binding affinities of protonating groups are, in general, different for H+ and D+. 
For this reason, the apparent pKa values, measured in D2O and expressed using pD, which is a 
measure of D+ concentration, are not similar to the corresponding values, measured in H2O 
and expressed in pH, which is a measure of H+ concentration.  
The direct determination of pD is not feasible, as pH electrodes are calibrated with buffer 
solutions in H2O. Therefore, for heavy water, the actual reading of the pH electrode and pH 
meter is pD not pH. The relationship between the dissociation of D2O and H2O is shown in the 
following equation: 
pH = pD – 0.5 
This equation came about because D2O is less dissociated than H2O, as mentioned above 
(Cook and Lister, 2014). This variation results in 0.50 unit shift between the pH of H2O and 
that of the pD for D2O. According to Popov et al. (2006), there are some factors that affect the 
correction value (C.V.) (0.5) that need to be subtracted to convert measured pD values to pH, 
which are the ionic strength of the compound and the temperature of the NMR sample. When 
these factors increase, the correction value (C.V.) increases.  
In order to confirm the validation of the correction value (C.V.), which is 0.5, the pKa values 
of the individual amino groups of neomycin C (3) and tobramycin (5) were measured using 
1H NMR spectroscopy in 100% H2O. The pKa values of amino groups on neomycin C (3) and 
tobramycin (5) that were measured in 100% H2O coincide, within the error bars ±0.05, with 
those determined in 99.97% D2O (see Fig. 4.4, Tables 4.2, 4.3 for neomycin C and Fig. 4.5, 
Tables 4.4, 4.5 for tobramycin). 
This study confirms that both the use of H2O solutions for determining pKa is entirely 
feasible, and that the use of the correction factor value, although seemingly an arbitrary 0.5 
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units, is in fact a reasonable approach. Recording NMR spectra in pure protio solvent is not 
without complications, not least the requirement for solvent suppression, and often NMR 
spectroscopic radiation damping effects leading to obscured resonances. 
 
Table 4.2 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b, H-2''', H-
6'''a, and H-6'''b of 0.215-0.120 M neomycin C were measured relative to TMSP in 100% H2O 
at 25°C at different pHs 
pH H-1 H-3 H-2' H-6’a H-6'b H-2''' H-6'''a H-6'''b 
2.00 3.4 3.59 3.46 3.37 3.47 3.61 3.31 3.43 
4.98 3.4 3.59 3.46 3.37 3.47 3.61 3.31 3.43 
6.71 3.32 3.36 3.42 3.35 3.48 3.55 3.26 3.39 
7.58 3.23 3.04 3.25 3.33 3.44 3.45 3.21 3.32 
8.55 2.9 2.88 2.91 3.15 3.2 3.21 3.16 3.21 
11.01 2.71 2.89 2.74 2.90 3.01 3.03 2.93 3.01 
 
























Fig. 4.4 NMR titration curves for the 1H chemical shifts () of 0.215-0.120 M neomycin C (3) 
were measured relative to TMSP in 100 % H2O at 25°C 
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Table 4.3 pKa values of individual nitrogen atoms of neomycin C in 99.97% D2O and 100% 
H2O, as indicated 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-6' N-2''' N-6''' 












1H NMR b 8.05 6.94 8.00 8.62 d 8.09 8.67 d 
 
a This work in 99.97% D2O 
b This work in 100% H2O 
c The pKa value of N-6' of neomycin C determined using 1H NMR spectroscopy (in this work in 99.97% 
D2O) is the average pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (8.65) 
and 6'b (8.70), and the pKa value of N-6''' of neomycin C determined using 1H NMR spectroscopy (in 
this work in 99.97% D2O) is the average pKa of the values of N-6''' obtained using 1H NMR 
spectroscopic data for 6'''a (8.72) and 6'''b (8.75) 
d  The pKa value of N-6' of neomycin C determined using 1H NMR spectroscopy (in this work in 100% 
H2O) is the average pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (8.60) 
and 6'b (8.65), and the pKa value of N-6''' of neomycin C determined using 1H NMR spectroscopy (in 
this work in 100% H2O) is the average pKa of the values of N-6''' obtained using 1H NMR spectroscopic 
data for 6'''a (8.65) and 6'''b (8.70) 
 
Table 4.4 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b, and H-3'' 
of 0.250-0.130 M tobramycin were measured relative to TMSP in 100 % H2O at 25°C at 
different pHs 
pH H-1 H-3 H-2' H-6'a H-6'b H-3'' 
3.01 3.65 3.61 3.68 3.31 3.45 3.52 
4.21 3.64 3.61 3.68 3.31 3.45 3.52 
5.71 3.62 3.49 3.55 3.28 3.45 3.51 
7.33 3.38 3.25 3.35 3.2 3.43 3.38 
8.81 3.04 3.01 3.13 5.95 3.31 3.10 
10.13 2.92 2.86 2.96 2.83 2.98 3.03 

























Fig. 4.5 NMR titration curves for the 1H chemical shifts () of 0.250-0.130 M tobramycin (5) 
were measured relative to TMSP in 100 % H2O at 25°C 
 
Table 4.5 pKa values of individual nitrogen atoms of tobramycin in 99.97% D2O and 100% 
H2O, as indicated 
Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 










1H NMR b 7.53 6.62 7.75 8.98 d 7.70 
 
a This work in 99.97% D2O 
b This work in 100% H2O 
c The pKa value of N-6' of tobramycin determined using 1H NMR spectroscopy (in this work in 99.97% 
D2O) is the average pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (9.05) 
and 6'b (9.10)  
d The pKa value of N-6' of tobramycin determined using 1H NMR spectroscopy (in this work in 100% 
H2O) is the average pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (8.90) 
and 6'b (9.05) 
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4.2. The effect of temperature and concentration on the pKa values of aminoglycoside 
antibiotics 
 
4.2.1. pD-dependent and temperature-dependent 1H and 13C NMR spectroscopic 
characterisations of 2-deoxystreptamine (1) and neomycin C (3) 
1H and 13C NMR spectroscopic data were measured at pD 1.44, pD 8.30, and pD 11.68 for 
2-deoxystreptamine and pD 1.25, pD 12.40 for neomycin, at three fixed temperature 25℃, 
35℃, and 50℃. The results showed that the chemical shifts () corresponding to the H-1/3 
and C-1/3 of 2-deoxystreptamine (1) and the chemical shifts () corresponding to the H-1, H-
3, H-2',H-6', H-2''', H-6''' and C-1, C-3, C-2', C-6', C-2''', C-6''' of neomycin C (3) did not shift 
with the increasing temperature from 25℃ to 50°C at low pD and high pD (see Figs. 4.6, 4.7 
for 2-deoxystreptamine and Figs. 4.8, 4.9 for neomycin C). One possible explanation of this 
observation is that the chemical shifts () of these protons and carbons of both 2-
deoxystreptamine (1) and neomycin C (3) were not temperature dependent. Thus, the pKa 
values of their amino groups on aminoglycosides will not be affected by increasing the 
temperature. 
 
4.2.2. pD-dependent and concentration-dependent 1H NMR spectroscopy 
characterisations of 2-deoxystreptamine (1) and neamine (2) 
1H NMR spectroscopic data were measured at two concentrations of 0.630 M and 0.157 M 
at low pD (~2) for 2-deoxystreptamine (1) and at 0.512 M and 0.128 M at high pD (~10) for 
neamine (2). The obtained results showed that the chemical shifts () corresponding to the H-
1/3 of 2-deoxystreptamine (1) and the chemical shifts () corresponding to the H-1, H-3, H-2', 
and H-6' of neamine (2) did not shift with the changing concentration levels. Thus, the pKa 
values of N-1/3 on 2-deoxystreptamine and N-1, N-3, N-2', and N-6' on neamine will not be 
affected by changing their concentrations, at least in this typical NMR concentration range 
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Fig. 4.6 1H NMR spectra of 0.159 M 2-deoxystreptamine (1) were measured relative to TMSP 
in 99.97% D2O at 25°C (red), 35°C (green), and 50°C (blue), A) at pD 1.44, B) at pD 8.30, 

























Fig 4.7 13C NMR spectra of 0.159 M 2-deoxystreptamine (1) were measured relative to TMSP 
in 99.97% D2O at 25°C (red), 35°C (green), and 50°C (blue), A) at pD 1.44, B) at pD 8.30, 




































Fig. 4.8 1H NMR spectra of 0.090 M neomycin C (3) were measured relative to TMSP in 











Fig. 4.9 13C NMR spectra of 0.090 M neomycin C (3) were measured relative to TMSP in 
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Fig. 4.10 1H NMR spectra of 2-deoxystreptamine (1) were measured relative to TMSP in 
99.97% D2O at 25°C, A) at concentration of 0.630 M and pD 1.88, B) at concentration of 
0.157 M and pD 2.00 
 
Fig. 4.11 1H NMR spectra of neamine (2) were measured relative to TMSP in 99.97% D2O at 
















4.3. Determination of the pKa values of the individual amino groups on aminoglycosides 
using 1H, 13C, and 15N HMBC NMR spectroscopy in D2O 
 
The sections 4.3.1 to 4.3.10 present the pKa values of the individual amines on 
aminoglycosides determined using 1H, 13C, and 15N HMBC NMR spectroscopy in this work. 
These data are compared with the published data (see Tables 4.9 for 2-deoxystreptamine, 4.13 
for neamine, 4.17 for neomycin C, 4.21 for paromomycin, 4.25 for tobramycin, 4.29 for 
kanamycin B, 4.33 for netilmicin, 4.37 for sisomicin,4.41 for amikacin, and 4.45 for 
streptomycin). 
The 1H, 13C, and 15N HMBC NMR spectroscopic experiments of 2-deoxystreptamine were 
repeated 3 times. Similarly, each NMR experiment was repeated twice for neamine, neomycin 
C, and tobramycin in order to calculate the error bars (Standard Deviation, SD) for the pH 
values, the chemical shifts (), and the pKa values (make 3, for 2-deoxystreptamine, or 2, for 
neamine, neomycin C, and tobramycin, samples of the same compound at the same pH and 
measure the NMR). It was observed that the majority of the error bars for the pH values and 
for the chemical shifts () were the same size as the plotted points (symbols) on the nonlinear 
sigmoidal curves. Therefore, having determined by experiments the typical size of the error 
bars, n=1 was judged to be sufficient for obtaining further NMR spectroscopic data. 
 
4.3.1. pKa values of the individual amino groups of 2-deoxystreptamine (1) 
 
Fig. 4.12 2-Deoxystreptamine (1) 
 
2-Deoxystreptamine (Fig. 4.12) is substituted with two primary amines on a cyclohexane 
ring. It is the central moiety of neamine, neomycin C, paromomycin, tobramycin, kanamycin 
B, netilmicin, sisomicin, and amikacin (see Fig. 4.1). The pKa determination using 1H, 13C, and 
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15N HMBC NMR were repeated 3 times (see Tables 4.6a, b, c, 4.7a, b, c, and 4.8a, b, c for 1H, 
13C and 15N chemical shifts, respectively). Tables 4.6d, 4.7d, and 4.8d show the average of 
Tables 4.6a, b, c, 4.7a, b, c, and 4.8a, b, c for 1H, 13C, and 15N chemical shifts, respectively (all 
the tables are shown in the appendix). The nonlinear sigmoidal curves are shown in Figs. 4.13a, 
b, 4.14a, b, 4.15, 4.16, 4.17, and 4.18. The pKa values of the two individual nitrogen atoms of 
2-deoxystreptamine, shown in Table 4.9 and Fig. 4.19, were extracted from the inflection 
points of the sigmoidal curves. 
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Fig. 4.13a NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.243-0.111 M 





















Fig. 4.13b NMR titration curve of H-1 and H-3, expanded from Fig. 4.13a. 
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Fig. 4.14a NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.243-0.111 




















Fig. 4.14b NMR titration curve of C-1 and C-3, expanded from Fig. 4.14a 
 















Fig. 4.15 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.631-
0.369 M 2-deoxystreptamine were measured relative to CH3NO2 in 99.97% D2O at 25°C 
 
It can be easily seen that the two inflections on the sigmoidal curves of H-3, H-1, and C-
3, C-1, and N-3, N-1, as shown in Figs. 4.13b, 4.14b, and 4.15, respectively, are not best-
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fitted curves, they are shown as point-joining curves. However, there is no available choice 
to draw best-fitted curves of multiple inflections curves (in these case each line has two 
inflections) using GraphPad Prism. For this reason, the two inflections on the sigmoidal 
curves of H-3, H-1, and C-3, C-1, and N-3, N-1 have been separated and drawn separately as 
lines of best-fit (see Figs. 4.16 and 4.17 and 4.18). 
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Table 4.9 pKa values of individual nitrogen atoms of 2-deoxystreptamine determined using 
1H, 13C, and 15N HMBC NMR spectroscopy in this work 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 
1H NMR b 9.25 ± 0.05 6.97 ± 0.04 
13C NMR b 9.35 ± 0.10 7.03 ± 0.05 




Fig. 4.19 pKa values of individual nitrogen atoms of 2-deoxystreptamine determined using 1H 
(red), 13C (blue), and 15N HMBC (green) NMR spectroscopy 
 
Due to the symmetrical character of 2-deoxystreptamine, the signals of H-1/3, C-1/3, and 
N-1/3 have same chemical shifts (). Therefore, there are two inflections in the H-1/3, C-1/3, 
and N-1/3 sigmoidal curves. The inflection point of each inflection represent a pKa value (see 
Figs. 4.13b, 4.14b, 4.15, and Fig. 4.20). 
In this work, the amines on 2-deoxystreptamine were numbered by comparing them to the 
2-deoxystreptamine ring of neamine (2), neomycin C (3), paromomycin (4), tobramycin (5), 





Fig. 4.20 Protonation scheme of 2-deoxystreptamine (1) containing two amino groups. 
 
4.3.2. pKa values of the individual amino groups of neamine (2) 
 
Fig. 4.21 Neamine (2) 
 
Neamine includes four primary amines around two rings, one of which is 2-deoxy-
streptamine, the other is a D-sugar on a glucose hexose template (see Fig. 4.21). All the pKa 
determinations using 1H, 13C, and 15N HMBC NMR spectroscopy were repeated twice. The 
average of the chemical shifts of 1H, 13C, and 15N HMBC of neamine at different pHs, shown 
in Tables 4.10, 4.11, and 4.12, were plotted against the pH values of the solution (all the tables 
are shown in the appendix). The nonlinear sigmoidal curves are shown in Figs. 4.22, 4.23, and 
4.24. The pKa values of each individual nitrogen atom of neamine, shown in Table 4.13 and 
Fig. 4.25, were then extracted from the inflection points of the sigmoidal curves. 
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Fig. 4.22 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.243-0.155 M 
neamine were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.23 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.243-0.155 

























Fig. 4.24 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.243-
0.155 M neamine were measured relative to CH3NO2 in 99.97% D2O at 25°C 
 
Table 4.13 pKa values of individual nitrogen atoms of neamine determined using 1H, 13C, and 
15N HMBC NMR spectroscopy in this work and then compared with the published data, as 
indicated 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-6' 
1H NMR a 7.77 6.44 7.23 8.08 
1H NMR b 7.62 ± 0.03 6.50 ± 0.04 7.10 ± 0.05 8.34 ± 0.05 c 
13C NMR b 7.60 ± 0.05 6.55 ± 0.05 7.05 ± 0.05 8.25 ± 0.05 
15N HMBC NMR b 7.60 ± 0.05 6.50 ± 0.05 7.20 ± 0.10 8.35 ± 0.05 
 
a pKa values of individual nitrogen atoms of neamine determined using 1H NMR spectroscopy in D2O 
relative to the HDO peak at 25°C (Andac et al., 2011) 
b This work 
c The pKa value of N-6' of neamine determined using 1H NMR spectroscopy (in this work) is the average 





Fig. 4.25 pKa values of individual nitrogen atoms of neamine determined using 1H (red), 13C 
(blue), and 15N HMBC (green) NMR spectroscopy 
 
After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, for each individual nitrogen atom on neamine are:  N-1 = 7.60, N-3 = 6.51, N-2' = 7.11, 
and N-6' = 8.31. The assignment order of the average ionisation constants is:  N-6' > N-1 > N-
2' > N-3. These pKa values are consistent in magnitude and in assignment order with these 
reported in the literature (Andac et al., 2011). 
 
4.3.3. pKa values of the individual amino groups of neomycin C (3) 
 
 




Neomycin C has six primary amines. Those amines are substituents on two aminosugar 
rings:  D-neosamine and L-neosamine and a central cyclohexane ring (2-deoxystreptamine). 
These three 6-membered rings are themselves O-substituents pendant from a D-ribose 
furanose ring. Neomycin C is a 4,5-O-disubstituted 2-deoxystreptamine (see Fig. 4.26). The 
pKa determinations using 1H, 13C, and 15N HMBC NMR spectroscopy were repeated twice. 
The average of the chemical shifts of 1H, 13C, and 15N HMBC of neomycin at different pHs, 
shown in Tables 4.14, 4.15, and 4.16, were plotted against the pH values of the solution (all 
the tables are shown in the appendix). The nonlinear sigmoidal curves are shown in Figs. 4.27, 
4.28, and 4.29. The pKa values of individual nitrogen atoms of neomycin C, shown in Table 
4.17 and Fig. 4.30, were extracted from the inflection points of the sigmoidal curves. 
























Fig. 4.27 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.218-0.122 M 
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Fig. 4.28 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.218-0.122 
M neomycin C were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.29 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.392-




Table 4.17 pKa values of individual nitrogen atoms of neomycin C determined using 1H, 13C, 
and 15N HMBC NMR spectroscopy and then compared with the published data, as indicated 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-6' N-2''' N-6''' 
15N NMR a 7.90 5.70 7.40 8.10 7.70 8.70 
15N NMR b 8.04 5.74 7.55 8.60 7.60 8.80 
15N NMR c 8.70 6.90 8.20 9.20 8.30 9.50 
1H-13C HSQC NMR d 8.10 5.40 7.40 8.70 7.50 8.80 







































a pKa values of individual nitrogen atoms of neomycin determined using 15N NMR spectroscopy in 
H2O/D2O (90: 10 v/v) relative to 15NH4Cl at 25°C (Özen et al., 2006) 
b pKa values of individual nitrogen atoms of neomycin determined using 15N NMR spectroscopy in 
H2O/D2O (85: 15 v/v) relative to NH415NO3 at 25°C (Botto and Coxon, 1982) 
c pKa values of individual nitrogen atoms of neomycin determined using 15N NMR spectroscopy in 
H2O/D2O (90:10 v/v) relative to NH3 by using 1.0 M 15N urea in DMSO at 25°C (Kaul et al., 2003) 
d pKa values of individual nitrogen atoms of neomycin determined using 1H and 13C HSQC NMR 
spectroscopy in D2O at 25°C (Freire et al., 2007) 
e This work 
f The pKa value of N-6' of neomycin C determined using 1H NMR spectroscopy (in this work) is the 
average pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (8.65) and 6'b 
(8.70), and the pKa value of N-6''' of neomycin C determined using 1H NMR spectroscopy (in this work) 





Fig. 4.30 pKa values of individual nitrogen atoms of neomycin C determined using 1H (red), 
13C (blue), and 15N HMBC (green) NMR spectroscopy 
 
After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, of each individual nitrogen atom on neomycin C are:  N-1 = 8.08, N-3 = 6.86, N-2' = 
7.98, N-6' = 8.65, N-2''' = 8.03, and N-6''' = 8.76. The assignment order of the average 
ionisation constants is:  N-6''' > N-6' > N-1 ≈ N-2' ≈ N-2''' > N-3 which is a revision of the 
assignment order reported in the literature. In the literature, the pKa values of these amines on 
neomycin have been measured using one technique either 15N NMR or 1H-13C HSQC NMR. 
Spectroscopy (Botto and Coxon, 1982; Kaul et al., 2003; Özen et al., 2006; Freire et al., 2007). 
However, in this study we have obtained the average pKa values using 1H, 13C, and 15N HMBC 








4.3.4. pKa values of the individual amino groups of paromomycin (4) 
 
 
Fig. 4.31 Paromomycin (4) 
 
Paromomycin has five primary amines. Those amines are substituents on two aminosugar 
rings:  2-amino-2-deoxy-D-glucose and L-neosamine and a central cyclohexane ring (2-
deoxystreptamine). These three 6-membered rings are themselves O-substituents pendant 
from a D-ribose furanose ring. Paromomycin is a 4,5-O-disubstituted 2-deoxystreptamine (see 
Fig. 4.31). The chemical shifts of 1H, 13C, and 15N HMBC of paromomycin at different pHs, 
shown in Tables 4.18, 4.19, and 4.20, were plotted against the pH values of the solution (all 
the tables are shown in the appendix). The nonlinear sigmoidal curves are shown in Figs. 4.32, 
4.33, and 4.34. The pKa values of individual nitrogen atoms of paromomycin, shown in Table 



























Fig. 4.32 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.335-0.208 M 
paromomycin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.33 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.335-0.208 
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Fig. 4.34 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.335-
0.208 M paromomycin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
 
Table 4.21 pKa values of individual nitrogen atoms of paromomycin determined using 1H, 13C, 
and 15N HMBC NMR spectroscopy in this work and then compared with the published data, 
as indicated 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-2''' N-6''' 
15N NMR a 8.20  6.50 8.07 7.91 9.13 
15N NMR b 8.65  7.07  8.33  8.25 9.46 
1H NMR c 8.25 6.45 8.10 8.20 9.15 d 
13C NMR c 8.10 6.55 8.00 8.11 9.00 
15N HMBC NMR c 8.00 6.50 8.10 8.00 9.10 
 
a pKa values of individual nitrogen atoms of paromomycin determined using 15N NMR spectroscopy in 
H2O/D2O (85: 15 v/v) relative to NH3 using 1 M [15N] urea in DMSO at 25°C (Barbieri and Pilch, 2006) 
b pKa values of individual nitrogen atoms of paromomycin determined using 15N NMR spectroscopy in 
H2O/D2O (85: 15 v/v) relative to NH3 using 1 M [15N] urea in DMSO at 25°C (Kaul et al., 2003) 
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c This work 
d The pKa value of N-6''' of paromomycin determined using 1H NMR spectroscopy (in this work) is the 
average pKa of the values of N-6''' obtained using 1H NMR spectroscopic data for 6'''a (9.14) and 6'''b 
(9.16) 
 
Fig. 4.35 pKa values of individual nitrogen atoms of paromomycin determined using 1H (red), 
13C (blue), and 15N HMBC (green) NMR spectroscopy 
After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, for each individual nitrogen atom on paromomycin are:  N-1 = 8.11, N-3 = 6.50, N-2' = 
8.06, N-2''' = 8.10, and N-6''' = 9.08, the new assignment order of the average ionisation 
constants is:  N-6''' > N-1 ≈ N-2' ≈ N-2''' > N-3. These pKa values require a minor revision of 
the assignment order reported in the literature. In the literature, the pKa values of these amines 
on paromomycin have been measured using one technique which is 15N NMR. Spectroscopy 
(Kaul et al., 2003; Barbieri and Pilch, 2006). However, in this study we have obtained the 









4.3.5. pKa values of the individual amino groups of tobramycin (5) 
 
Fig. 4.36 Tobramycin (5) 
 
Tobramycin has five primary amines. Those amines are substituents on two aminosugar 
rings:  3-deoxykanosamine (nebrosamine) and 3-amino-3-deoxy-D-glucose, and a central 
cyclohexane ring (2-deoxystreptamine). Tobramycin is a 4,6-O-disubstituted 2-
deoxystreptamine (see Fig. 4.36). The pKa determinations using 1H, 13C, and 15N HMBC NMR 
spectroscopy were repeated twice. The average of the chemical shifts of 1H, 13C, and 15N 
HMBC of tobramycin at different pHs, shown in Tables 4.22, 4.23, and 4.24, were plotted 
against the pH values of the solution (all the tables are shown in the appendix). The nonlinear 
sigmoidal curves are shown in Figs. 4.37, 4.38, and 4.39. The pKa values of individual nitrogen 
atoms of tobramycin, shown in Table 4.25 and Fig. 4.40, were extracted from the inflection 
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Fig. 4.37 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.251-0.132 M 
tobramycin were measured relative to TMSP in 99.97% D2O at 25°C 
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 Fig. 4.38 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.251-0.132 
M tobramycin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.39 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.740-
0.370 M tobramycin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
 
Table 4.25 pKa values of individual nitrogen atoms of tobramycin determined using 1H, 13C, 
and 15N HMBC NMR spectroscopy in this work and then compared with the published data, 
as indicated 
Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 
15N NMR a 7.40 6.20 7.60 8.60 7.40 
1H NMR b 7.30 6.60 7.50 8.40 7.30 
15N NMR b 7.40 6.40 7.70 8.50 7.40 































a pKa values of individual nitrogen atoms of tobramycin determined using 15N NMR spectroscopy in 
H2O/D2O (90: 10 v/v) relative to 15NH4Cl at 25°C (Dorman et al., 1976) 
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b pKa values of individual nitrogen atoms of tobramycin determined using 1H NMR spectroscopy and 
15N NMR spectroscopy in D2O relative to TMS at 25°C (Pagano et al., 2011) 
c This work  
d The pKa value of N-6' of tobramycin determined using 1H NMR spectroscopy (in this work) is the 
average pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (9.05) and 6'b 
(9.10) 
 
Fig. 4.40 pKa values of individual nitrogen atoms of tobramycin determined using 1H (red), 
13C (blue), and 15N HMBC (green) NMR spectroscopy 
After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, of each individual nitrogen atom on tobramycin are:  N-1 = 7.55, N-3 = 6.70, N-2' = 7.75, 
N-6' = 9.10, and N-3'' = 7.68. The assignment order of the average ionisation constants within 
± 0.05 is:  N-6' > N-2' ≈ N-3'' > N-1 > N-3. These pKa values are consistent in assignment order 
with these reported in the literature (Dorman et al., 1976; Pagano et al., 2011). 
 
4.3.6. pKa values of the individual amino groups of kanamycin B (6) 
 




Kanamycin B has five amines. Those amines are substituents on two aminosugar rings:  3-
amino-3-deoxy-D-glucose and 6-amino-6-deoxy-D-glucose, and a central cyclohexane ring 
(2-deoxystreptamine). Kanamycin B is a 4,6-O-disubstituted 2-deoxystreptamine (see Fig. 
4.41). The chemical shifts of 1H, 13C, and 15N HMBC of kanamycin B at different pHs, shown 
in Tables 4.26, 4.27, and 4.28, were plotted against the pH values of the solution (all the tables 
are shown in the appendix). The nonlinear sigmoidal are shown in Figs. 4.42, 4.43, and 4.44. 
The pKa values of individual nitrogen atoms of kanamycin B, shown in Table 29 and Fig. 4.45, 
were extracted from the inflection points of the sigmoidal curves. 
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Fig. 4.42 NMR titration curves for the 1H chemical shifts () (500 MHz) of 1.315-0.822 M 




















C - 2 '
C - 6 '
C -3 ''
 
Fig. 4.43 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 1.315-0.822 
M kanamycin B were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.44 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 1.315-




Table 4.29 pKa values of individual nitrogen atoms of kanamycin B determined using 1H, 13C, 
and 15N HMBC NMR spectroscopy in this work and then compared with the published data, 
as indicated 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' N-6' N-3'' 
1H NMR a 8.12 6.04 - 9.03 7.46 
1H NMR b 8.16 6.71 7.35 8.93c 7.60 
13C NMR b 8.10 6.80 7.40 9.10 7.70 
15N HMBC NMR b 8.05 6.85 7.35 8.90 7.65 
 
a pKa values of individual nitrogen atoms of kanamycin A (note, which lacks an N-2' amine) determined 
using 1H NMR spectroscopy in D2O relative to TSP at 25°C (Gutiérrez-Moreno et al., 2012). Note also 
that there are no literature data for the pKa values of kanamycin B. 
b This work 
c The pKa value of N-6' of kanamycin B determined using 1H NMR spectroscopy (in this work) is the 





Fig. 4.45 pKa values of individual nitrogen atoms of kanamycin B determined using 1H (red), 




After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, of each individual nitrogen atom on kanamycin B are:  N-1 = 8.10, N-3 = 6.78, N-2' = 
7.36, N-6' = 8.97, and N-3'' = 7.65. The assignment order of the average ionisation constants 
is:  N-6' > N-1 > N-3'' > N-2' > N-3. In the absence of any kanamycin B published pKa data 
determined using NMR spectroscopy, these are therefore reported for the first time. 
 
4.3.7. pKa values of the individual amino groups of netilmicin (7) 
 
Fig. 4.46 Netilmicin (7) 
 
Netilmicin includes five amines, which are substituents on two aminosugar rings: dehydro-
purpurosamine and garosamine and a central cyclohexane ring (2-deoxystreptamine) (see Fig. 
4.46). There are two different N-alkyl substituents:  N-ethyl on N-1 and N-methyl on N-3''. 
The chemical shifts of 1H, 13C, and 15N HMBC of netilmicin at different pHs, shown in Tables 
4.30, 4.31, and 4.32, were plotted against the pH values of the solution (all the tables are shown 
in the appendix). The nonlinear sigmoidal curves are shown in Figs. 4.47, 4.48, and 4.49. The 
pKa values of individual nitrogen atoms of netilmicin, shown in Table 4.33 and Fig. 4.50, were 
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Fig. 4.47 NMR titration curves for the 1H chemical shifts () (500 MHz) 0.506-0.434 M 
netilmicin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.48 NMR titration curves for the 13C chemical shifts (ppm) (125.77 MHz) of 0.506-0.434 
M netilmicin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.49 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.506-
0.434 M netilmicin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
 
Table 4.33 pKa values of individual nitrogen atoms of netilmicin determined using 1H, 13C, 
and 15N HMBC NMR spectroscopy in this work 
Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 
1H NMR a 8.15 6.55 8.10 9.27 b 8.48 
13C NMR a 8.11 6.50 8.11 9.32 8.50 
15N HMBC NMR a 8.20 6.51 8.23 9.37 8.45 
 
a This work. As far as can be determined, there are no literature data for the pKa values of netilmicin. 
b The pKa value of N-6' of netilmicin determined using 1H NMR spectroscopy (in this work) is the 







Fig. 4.50 pKa values of individual nitrogen atoms of netilmicin determined using 1H (red), 13C 
(blue), and 15N HMBC (green) NMR spectroscopy 
 
In the absence of any netilmicin published pKa data, these are therefore reported for the 
first time. The average pKa values are:  N-1 = 8.15, N-3 = 6.52, N-2' = 8.14, N-6' = 9.29, and 
N-3'' = 8.47 and these are assigned in this order:  N-6' > N-3'' > N-1 ≈ N-2' > N-3. 
 
4.3.8. pKa values of the individual amino groups of sisomicin (8) 
 
Fig. 4.51 Sisomicin (8) 
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Sisomicin includes four primary amines and a secondary (N-methyl) amine. Those amines 
are substituents on two aminosugar rings: dehydro-purpurosamine and garosamine and a 
central cyclohexane ring (2-deoxystreptamine) (see Fig. 4.51). The chemical structure of 
sisomicin is similar to that of netilmicin, with a primary amine as N-1 for the N-ethyl of 
netilmicin the only difference (see Figs. 4.1, 4.46 and 4.51). The chemical shifts of 1H, 13C, 
and 15N HMBC of sisomicin at different pHs, shown in Tables 4.34, 4.35, and 4.36, were 
plotted against the pH values of the solution (all the tables are shown in the appendix). The 
nonlinear sigmoidal curves are shown in Figs. 4.52, 4.53, and 4.54. The pKa values of 
individual nitrogen atoms of sisomicin, shown in Table 4.37 and Fig. 4.55, were extracted 
from the inflection points of the sigmoidal curves. 
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Fig. 4.52 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.083-0.063 M 
sisomicin were measured relative to TMSP in 99.97% D2O at 25°C at different pHs 
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Fig. 4.53 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.083-0.063 
M sisomicin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.54 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.160-




Table 4.37 pKa values of individual nitrogen atoms of sisomicin determined using 1H, 13C, and 
15N HMBC NMR spectroscopy in this work and then compared with the published data, as 
indicated 
Individual nitrogen atoms pKa 
Method 
N-1  N-3  N-2' N-6' N-3'' 
1H NMR a 7.34 6.11 7.93 9.45 8.63 
1H NMR b 7.42 6.18 7.98 9.35 c 8.51  
13C NMR b 7.45 6.25 7.99 9.28 8.45 
15N HMBC NMR b 7.41 6.24 8.05 9.29 8.55 
 
a pKa values of individual nitrogen atoms of sisomicin determined using 1H NMR spectroscopy in D2O 
relative to TSP at 25°C (Krężel et al., 2004) 
b This work 
c The pKa value of N-6' of sisomicin determined using 1H NMR spectroscopy (in this work) is the average 
pKa of the values of N-6' obtained using 1H NMR spectroscopic data for 6'a (9.35) and 6'b (9.35), which 
gave the same value 
 
Fig. 4.55 pKa values of individual nitrogen atoms of sisomicin determined using 1H (red), 13C 




After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, of each individual nitrogen atom on sisomicin are:  N-1 = 7.42, N-3 = 6.22, N-2' = 8.00, 
N-6' = 9.30, and N-3'' = 8.50. The assignment order of the average ionisation constants is:  N-
6' > N-3'' > N-2' > N-1 > N-3. These pKa values are consistent in magnitude and in assignment 
order with these reported in the literature (Krężel et al., 2004). 
 
4.3.9. pKa values of the individual amino groups of amikacin (9) 
 
 
Fig. 4.56 Amikacin (9) 
 
Amikacin includes four amines, which are substituents on two aminosugar rings:  3-amino-
3-deoxy-D-glucose and 6-amino-6-deoxy-D-glucose, a central cyclohexane ring (2-
deoxystreptamine), and L-amino--hydroxybutanoic acid (see Fig. 4.56). The chemical shifts 
of 1H, 13C, and 15N HMBC of amikacin at different pHs, shown in Tables 4.38, 4.39, and 4.40, 
were plotted against the pH values of the solution (all the tables are shown in the appendix). 
The nonlinear sigmoidal curves are shown in Fig. 4.57, 4.58, and 4.59. The pKa values of the 
individual amino groups of amikacin, shown in Table 4.41 and Fig. 4.60, were extracted from 

























Fig. 4.57 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.896-0.597 M 
amikacin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.58 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.896-0.597 
M amikacin were measured relative to TMSP in 99.97% D2O at 25°C 
103 
 

















N - 3 ''
N -4 '' '
 
Fig. 4.59 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.896-
0.597 M amikacin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
 
Table 4.41 pKa values of individual nitrogen atoms of amikacin determined using 1H, 13C, and 
15N HMBC NMR spectroscopy in this work and then compared with the published data, as 
indicated 
Individual nitrogen atoms pKa 
Method 
N-3 N-6' N-3'' N-4''' 
15N NMR a 7.62 8.92 8.13 9.70 
1H NMR b 7.70 8.93 c 8.05 9.92 
13C NMR b 7.63 8.70 8.00 9.85 
15N HMBC NMR b 7.60 8.80 8.10 9.90 
 
a pKa values of individual nitrogen atoms of amikacin determined using 15N NMR spectroscopy in 
H2O/D2O (85: 15 v/v) relative to 15NH4Cl at 25°C (Cox and Serpersu, 1997) 
b This work 
c The pKa value of N-6' of amikacin determined using 1H NMR spectroscopy (in this work) is the average 




Fig. 4.60 pKa values of individual nitrogen atoms of amikacin determined using 1H (red), 13C 
(blue), and 15N HMBC (green) NMR spectroscopy 
 
After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, of each amino group on amikacin are:  N-3 = 7.64, N-6' = 8.81, N-3'' = 8.05, and N-4''' = 
9.89. The assignment order of the average ionisation constants is:  N-4''' > N-6' > N-3'' > N-3. 
These pKa values are consistent in magnitude and in assignment order with these reported in 
the literature (Cox and Serpersu, 1997). 
 








Streptomycin has seven nitrogen atoms distributed within two guanidine groups on 
streptidine and a secondary amine (N-methyl) on an N-methyl-1-glucosamine ring (see Fig. 
4.61). The streptose ring with its 6-carbon atoms is a furanose, not a pyranose, and also it is 
not a linear sugar with its methyl and an aldehyde functional group. The chemical shifts of 1H, 
13C, and 15N HMBC of streptomycin at different pHs, shown in Tables 4.42, 4.43, and 4.44, 
were plotted against the pH values of the solution (all the tables are shown in the appendix). 
The nonlinear sigmoidal curves are shown in Figs. 4.62, 4.63, 4.64, and 4.65. The individual 
pKa values of the two guanidine groups (N-1 and N-3) and the secondary amine (N-methyl) of 
streptomycin, shown in Table 4.45 and Fig. 4.66, were extracted from the inflection points of 
the sigmoidal curves. 
 
 


















Fig. 4.62 NMR titration curves for the 1H chemical shifts () (500 MHz) of 0.738-0.527 M 
streptomycin were measured relative to TMSP in 99.97% D2O at 25°C 
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Fig. 4.63 NMR titration curves for the 13C chemical shifts () (125.77 MHz) of 0.738-0.527 
M streptomycin were measured relative to TMSP in 99.97% D2O at 25°C 
 
















Fig. 4.64 NMR titration curves for the 15N HMBC chemical shifts () (50.67 MHz) of 0.738-



































Fig. 4.65 NMR titration curves of A) N-1, N-3 and B) N-2', expanded from Fig. 4.55 
 
Table 4.45 pKa values of the two guanidine groups (N-1 and N-3) and the secondary amine 
(N-methyl) N-2' of streptomycin determined using 1H, 13C, and 15N HMBC NMR spectroscopy 
in this work and then compared with the published data, as indicated 
Individual nitrogen atoms pKa 
Method 
N-1 N-3 N-2' 
1H NMR a 13.55 12.33 8.29 
1H NMR b 13.20 12.10 8.38 
13C NMR b 13.02 11.95 8.11 
15N NMR b 12.97 12.15 8.01 
 
a pKa values of individual nitrogen atoms of streptomycin determined using 1H NMR spectroscopy in 
H2O/D2O (95: 05 v/v) relative to DSS at 25°C (Orgován and Noszál, 2012). 
b This work 
 
After calculating the average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic 
data, of the two guanidine groups (N-1 and N-3) and the secondary amine (N-methyl) on 
streptomycin are:  N-1 (guanidine) = 13.06, N-3 (guanidine) = 12.06, and N-2' = 8.16. The 
assignment order of the average ionisation constants is:  N-1 > N-3 > N-2'. These pKa values 






Fig. 4.66 pKa values of individual nitrogen atoms of streptomycin determined using 1H (red), 
13C (blue), and 15N HMBC (green) NMR spectroscopy 
 
4.3.11. General discussion of section 4.3 
 
The pKa values of N-3 of neamine (2) (6.50), paromomycin (4) (6.50), tobramycin (5) 
(6.70), kanamycin B (6) (6.78), netilmicin (7) (6.52), sisomicin (8) (6.22), and neomycin C (3) 
(6.86), were the lowest pKa value among other amines on these aminoglycosides. The reason 
for the lowering of the pKa values of N-3 amino groups compare to other amines located on 
these natural products is the inductive effect of the neighbouring NH3+-1 (short distance 
between N-1 and N-3 at 2-deoxystreptamine ring) (Cox and Serpersu, 1997; Krężel et al., 
2004). 
Depending on both the chemical structures and the acid-base properties of 
aminoglycosides, the amino substituents can be classified into four groups, as follows:  
primary amines, attached directly to the amino-sugar ring (R-NH2), primary amino methylene 
groups (R-CH2NH2), primary amines in the aliphatic chains and the secondary amines attached 
directly to the amino-sugar ring. 1H, 13C, and 15N HMBC NMR spectroscopic data indicated 
that the lowest pKa values were the primary amines (R-NH2) attached directly to the sugar ring. 
Side-chain amino groups (on amikacin) and guanidine groups (on streptomycin) had the 
highest pKa value. The average pKa values for the primary amines attached directly to the 
aminosugar ring (R-NH2) using 1H, 13C, and 15N HMBC NMR spectroscopic data is 7.53, for 
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the secondary amines is 8.32, for the primary amino methylene groups (R-CH2NH2) is 8.91, 
for the side-chain amino groups is 9.89, and for the guanidine groups is 12.56 (see Table 4.46). 
This observation might result from the side chain amino groups being less sterically hindered 
than the primary aminomethylene groups (R-CH2NH2) and the primary amines attached 
directly to the aminosugar rings (R-NH2), respectively and the electron donating effects of 
alkyl groups on the pKa values of the Side-chain amino groups and primary amino methylene 
groups (R-CH2NH2) (Krężel et al., 2004). 
The pKa values of the amino groups of netilmicin (7) and sisomicin (8) antibiotics are 
higher pKa values (more basic) than the other aminoglycosides that contains 2-
deoxystreptamine ring (see sections 4.1.7 for netilmicin and 4.1.8 for sisomicin). Some 
differences in their structures, methylation of N-3'' and ethylation of N-1 in netilmicin (7) or 
methylation of N-3'' in sisomicin (8). Moreover, the electron donationg effects of alkyl groups 
on N-1 and N-3'' of netilmicin and on N-3'' of sisomicin could explain the increasing in the 
pKa value of N-1 and N-3'' of netilmicin and N-3'' of sisomicin (see Fig. 4.1 and Table 4.47) 
(Krężel et al., 2004).  
 
Table 4.46 Comparison of the average pKa values for aminoglycosides with the number of 
amino groups of particular types indicated 




pKa (av) 7.53 8.32 8.91 9.89 12.56 
 
1°. Primary amine 
2°. Secondary amine 





Table 4.47 The average pKa values of individual nitrogen atoms of the indicated 
aminoglycosides using 1H, 13C, and 15N HMBC NMR spectroscopy  
Individual nitrogen atoms pKa 
aminoglycoside 
N-1 N-3 N-2' N-6' N-3'' N-2''' N-4''' N-6''' 
neomycin C 8.08 6.86 7.98 8.65 - 8.03 - 8.76 
paromomycin 8.11 6.50 8.06 - - 8.10 - 9.08 
tobramycin 7.55 6.70 7.75 9.10 7.68 - - - 
kanamycin B 8.10 6.78 7.36 8.97 7.65 - - - 
amikacin - 7.64 - 8.81 8.05 - 9.89 - 
sisomicin  7.42 6.22 8.00 9.30 8.50 - - - 
netilmicin 8.15 6.52 8.14 9.29 8.47 - - - 
 
pKa (av). The average pKa values using 1H, 13C, and 15N NMR spectroscopy 
 
In the case of streptomycin (10), streptomycin has two guanidine groups that are more 
basic than side-chain amino groups, primary aminomethylene groups, and primary amines 
attached directly to the aminosugar rings. The stability of the conjugate acid of guanidine 
groups could explain this phenomenon.  
It is clearly seen that its first protonation will begin at high pH, ~15 (1%), on guanidine 
N-1. Then becoming  more protonated, 10% at pH ~14, and reaching 50% protonated at the 
pKa value of guanidine N-1, pKa = 13.06. This functional group is therefore found to be 10-
fold more basic than guanidine N-3 with its pKa = 12.06. The reasons behind this different 
basicity possibly include that the inductive effect of the ether group on C-4 might decrease 
the pKa value of guanidine N-3, taken together with guanidine N-1 being less sterically 
hindered than guanidine N-3. The second (N-3) and third (N-2') protonations of streptomycin 
(10) are highly separated, each occurring to 50% at pH ~12.0 and ~8.0 respectively, as the 
secondary amino group (N-2') (pKa = 8.16) is 10,000-fold less basic than a guanidine group 
(section 4.1.10 and Fig. 4.67) (Orgován and Noszál, 2012). 
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The presence or absence of substituents (e.g. OH) is not just affecting the NMR chemical 
shifts, but also affecting the ionisation constants of amino groups located on the 
aminoglycosides. For example, the presence of a hydroxyl group on C-3' of kanamycin B (6) 
causes a decrease in the pKa of N-2', pKa = 7.75 of tobramycin (5) to 7.36 of N-2' of kanamycin 
B (Fig. 4.68). 
 
Fig. 4.67 The average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic data, of 






Fig. 4.68 The average pKa values, using 1H, 13C, and 15N HMBC NMR spectroscopic data, of 
individual nitrogen atoms of A) tobramycin and B) kanamycin B 
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4.4. Selective reactions of tobramycin with Boc and Cbz protecting groups, and FITC 
 
One of the ultimate objectives is to be able to trace an aminoglycoside, e.g., tobramycin 
(5), in the body in a non-invasive way by tagging the aminoglycoside with a fluorescent probe. 
The use of fluorescent derivatives of aminoglycosides may provide an insight to understand 
their mechanisms of toxicity. However, random FITC-labelling may present some obstacles 
in that it may prevent the clinical effectiveness of the aminoglycoside by labelling a crucial 
amine functional group and thereby blocking their biological activity. Therefore, this study 
aims to investigate a few specific or selective reactions of different amines located around 
tobramycin with amino acid protecting groups and with FITC. 
Taking both the pKa values (basicity) of amino groups and steric hindrance factors into 
consideration, the reaction of tobramycin (5) with 5 equiv. of (Boc)2O was carried out 
following the protocols in Michael et al. (1999) replacing neomycin with tobramycin. The 
desired penta-Boc compound 12 was obtained, as evidenced by HRMS: found 990.5203, 
C43H77NaN5O19 requires 990.5102 [M + Na]+. The reaction of tobramycin (5) with 4 equiv. of 
(Boc)2O was carried out following Michael et al. (1999) where tobramycin (5) was used 
instead of neomycin at a temperature of 0℃ instead of 60℃ (Fig. 4.69). The yield of tetra-
Boc compound 13 was 31%, because the product of the reaction of tobramycin (5) with 4 
equiv. of (Boc)2O was a mixture of compounds, penta-Boc 12 (32%) and tetra-Boc 13 (31%) 
displaying HRMS: found 868.491, C38H70N5O17 requires 868.471 [M + H]+. 
The reaction of 1 equiv. of (Boc)2O, using the same conditions for compound 13, was 
carried out on tobramycin (5), but this did not yield any of the desired compound 14. However, 
using 1 equiv. of O-Cbz-N-hydroxyphthalimide, following the protocols of Chandrika et al. 
(2015) at a temperature of 0℃ rather than at 20℃, was created with tobramycin (5) (see Fig. 
4.70). The desired compound 15 was detected using HRMS, however, due to the high polarity 
of compound 15, the separation process was difficult. 
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The comparison between 1H and 1H-13C HSQC NMR spectra of tobramycin (5), ', and 
compound 13 confirm that four out of five amines were protected with Boc groups on 
compound 13 as expected (see Figs. 4.71, 4.72, 4.73, 4.74, 4.75, and 4.76). 
Tables 4.48, 4.49 and Fig. 4.77 show 1H and 13C chemical shifts and chemical shift 
differences (between tobramycin (5) and penta-Boc compound 12, and tobramycin (5) 
and tetra-Boc compound 13The 1H and 13C chemical shift differences (of H-1, H-2', H-
6', H-3'' and C-1, C-2', C-6', C-3'' of tobramycin (5) and compound 12, and tobramycin (5) and 
compound 13 are similar. However, the 1H and 13C chemical shift differences (of H-3 and 
C-3 of tobramycin (5) and compound 13 were obviously less than the 1H and 13C chemical 
shift differences (of H-3 and C-3 of tobramycin (5) and compound 12. This strongly 
suggests that the unprotected amine of compound 13 was N-3.
The explanation for this might be that the average pKa value of N-3 using 1H, 13C and 15N 
NMR spectroscopy is 6.70 which is the lowest pKa value among those amines on tobramycin 
(5) (N-1, N-2', N-6' and N-3''), in other words, the basicity of N-3 is 251-times less than N-6' 
and 10-times less than N-1, N-2' and N-3''. Moreover, the N-3 is sterically more hindered than 
other amines on tobramycin (5). 
The reactions of compound 13 with FITC were attempted, following the protocols in 
Bandyopadhyay et al. (2017) for condition (i), except that the temperature of 80 ℃ for 27h 
was followed instead with a room temperature for 1h, and Litovchick al. (2001) for condition 
(ii), but this did not yield any of the desired fluorescent conjugate compound 16 (see Fig. 4.78). 
The possible explanation of this outcome is that the NH2-3 is too sterically hindered. 





Fig. 4.69 Reagents and conditions (i) DMF, H2O, Et3N, (Boc)2O (5 equiv.), 60℃ for 24h, 80% 






Fig. 4.70 Reagents and conditions (i) DMF, H2O, Et3N, (Boc)2O (1 equiv.) 0°C for 2h and 
20°C for 22h, 0% and (ii) MeOH: H2O (1:1), K2CO3, O-Cbz-N-hydroxyphthalimide  












Fig. 4.71 The 1H NMR spectrum of tobramycin (5) 
 
 






Fig. 4.73 The 1H NMR spectrum of compound 12 
 
 






Fig. 4.75 The 1H NMR spectrum of compound 13 
 
 




Fig. 4.77 Overlaid 1H-13C HSQC spectra for tobramycin (5 – in black), 12 (blue) and 13 





Fig. 4.78 Reagents and conditions (i) water/methanol/dioxane (1:1:1, v/v/v), FITC (2 equiv.) 








Table 4.48 1H and 13C chemical shift differences ( between tobramycin (5) and compound 
12. The red colour highlights the protons and carbons with nitrogen substituents. 
 1H 󠄀and 13C  between tobramycin (5) and compound 12 
1H 󠄀   13C 󠄀   
1 0.58 0.71 
2eq 0.30 1.48 
2ax 0.26 - 
3 0.67 0.46 
4 0.13 4.22 
5 0.04 0.43 
6 0.23 4.74 
1' 0.17 0.86 
2' 0.57 0.24 
3'eq 0.06 2.59 
3'ax 0.03 - 
4' 0.13 1.44 
5' 0.01 1.12 
6'a 0.48 1.12 
6'b 0.52 - 
1'' 0.06 1.08 
2'' 0.04 1.06 
3'' 0.68 1.18 
4'' 0.04 1.29 
5'' 0.05 1.07 
6''a 0.01 0.46 









Table 4.49 1H and 13C chemical shift differences ( between tobramycin (5) and compound 
13. The red colour highlights the protons and carbons with nitrogen substituents. 
 1H 󠄀and 13C  between tobramycin (5) and compound 13 
1H 󠄀  13C 󠄀   
1 0.63 0.79 
2eq 0.09 1.50 
2ax 0.06 - 
3 0.16 0.06 
4 0.08 1.02 
5 0.06 1.70 
6 0.25 5.76 
1' 0.12 2.67 
2' 0.65 0.21 
3'eq 0.01 2.81 
3'ax 0.03 - 
4' 0.15 2.01 
5' 0.02 0.57 
6'a 0.35 1.30 
6'b 0.51 - 
1'' 0.14 1.42 
2'' 0.01 1.54 
3'' 0.68 1.20 
4'' 0.04 2.90 
5'' 0.10 2.67 
6''a 0.01 1.21 











1H, 13C, and 15N NMR spectroscopy is a powerful technique for the measurement of 
individual pKa values. Unambiguous assignments have been made for each individual amine 
substituent on 2-deoxystreptamine (1), neamine (2), neomycin C (3), paromomycin (4), 
tobramycin (5), kanamycin B (6), netilmicin (7), sisomicin (8), amikacin (9), and streptomycin 
(10) using variations in the chemical shift () with 1H, 13C, and 15N HMBC NMR spectroscopy. 
The average pKa values using 1H, 13C, and 15N HMBC NMR spectroscopic data for amines on 
2-deoxystreptamine (1), neamine (2), neomycin C (3), paromomycin (4), tobramycin (5), 
kanamycin B (6), for netilmicin (7), sisomicin (8), amikacin (9), and streptomycin (10) are 
shown in Fig. 4.79. Due to its sensitivity, 1H NMR spectroscopy is less time consuming (2 min 
for each sample) than 13C (30 min for each sample) and 15N HMBC (45 min for each sample) 
NMR spectroscopy. Consequently, 1H NMR spectroscopy is the most preferable method for 
measuring individual pKa values. 
Taking both the pKa values (basicity) of amino groups of tobramycin and steric hindrance 
factors into consideration, the investigation of the specific or selective reactions of the different 
amines located around tobramycin with amino acid protecting groups, e.g., Boc and Cbz, and 
with a fluorophore (FITC) that would generate a biologically relevant tagged tobramycin were 
carried out. The 1H and 13C NMR spectroscopic data of compounds 12 and 13 confirm that 
four out of five amines on tobramycin (5) were protected with Boc groups and the unprotected 
(unreacted) amine was N-3, which has the lowest pKa value. However, the mono-protections 
of tobramycin (5) with Boc or Cbz groups and labelling the unprotected amine (N-3) on tetra-
Boc compound 13 with FITC were not successful. 
These results demonstrate amine basicity, and therefore reactivivity, can be predicted by 
NMR techniques, which can lead to selective functionalisation. One of the ultimate objectives 
is to be able to trace an aminoglycoside in the body in a non-invasive way by tagging the 
aminoglycoside with a fluorescent probe. Using the techniques described in this report, we can 
predict and synthesise specific FITC-labeled fluorescent derivatives of aminoglycosides that 





Fig. 4.79 The average pKa values of individual nitrogen atoms of 2-deoxystreptamine (1), 
neamine (2), neomycin C (3), paromomycin (4), tobramycin (5), kanamycin B (6), netilmicin 
(7), sisomicin (8), amikacin (9), and streptomycin (10) determined using 1H, 13C, and 15N 
HMBC NMR spectroscopy 
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Purpose 
The amino functional group substituents around the different rings of aminoglycoside antibiotics are 
key to the biological activities of these natural product alkaloids. The ionisation constant (pKa) is the 
pH at which functional groups are 50% ionized. The pKa values of any medication play a significant 
role in the physicochemical data and are relevant to drug activity. This study is on determining 
individual pKa values by detailed Nuclear Magnetic Resonance (NMR) spectroscopy of selected 
aminoglycoside alkaloids from Streptomyces and Micromonospora. In order to determine the 
individual pKa values, not available by potentiometric methods, different NMR reporter nuclei have 
been employed. Studying the pKa values of these alkaloids will afford a better understanding of their 
structure-activity relationships (SAR), especially the order in which these similar functional groups 
gain/lose protons. Such data will potentially help in understanding the order of target mRNA binding 
of key basic functional groups. The aim is to measure pKa values of individual amines on 
aminoglycosides by using new combinations of 1H, 13C, and 15N NMR spectroscopic data.  
Methods 
Aminoglycoside analyte solutions (0.73-0.15 M aminoglycoside in 99.97% D2O) were prepared at a 
~10 mg/mL concentration. NMR spectra including 1H, 13C, HSQC, HMBC, NOESY, and 15N-HMBC 
were recorded on Bruker Avance III 400 and 500 MHz spectrometers. Trimethylsilylpropanoic acid 
(TMSP) was used as a reference for 1H and 13C NMR spectroscopy. 15N chemical shifts were 
measured relative to external CH3NO2 set at -511.72 ppm. The pH values were adjusted using 0.5 M 
NaOD/DCl. MestReNova was used for analysis of the recorded spectra. The nonlinear sigmoidal 
curve and the inflection point of the sigmoidal curve were determined using GraphPad Prism 7 
(Version 2017), after subtraction of 0.5 to convert the measured pD values into pH values. 
Results 
The pKa values of 1-NH2 and 3-NH2 of 2-deoxystreptamine are 9.26 and 7.00. The order of ionisation 
constants for neamine is: N-6' (8.31) > N-1 (7.60) > N-2' (7.11) > N-3 (6.50), for neomycin is: 
N-6''' (8.76) > N-6' (8.65) > N-1 (8.08) ≈ N-2' (7.98) ≈ N-2''' (8.03) > N-3 (6.86), for tobramycin is:          
N-6' (9.10) > N-2' (7.75) ≈ N-3'' (7.68) > N-1 (7.55) > N-3 (6.70) and for sisomicin is: N-6' (9.30) > 
N-3'' (8.50) > N-2' (8.00) > N-1 (7.42) > N-3 (6.22). 
Conclusions 
1H, 13C, and 15N NMR spectroscopy is a powerful tool for the measurement of individual pKa values. 
Moreover, because of its sensitivity, 1H NMR spectroscopy is less time consuming (2 min for each 
sample) than 13C (30 min for each sample) and 15N HMBC (45 min for each sample) NMR 
spectroscopy. Unambiguous assignments have been made for each individual amine substituent on 
these clinically important aminoglycoside antibiotics. 
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Objectives 
The objectives of these studies are to measure the individual ionisation constant (pKa) values of each 
amine on selected aminoglycoside alkaloids from Streptomyces and Micromonospora by using new 
combinations of 1H, 13C, and 15N-HMBC NMR spectroscopic data. The pKa is the pH at which 
functional groups are 50% ionized. Any medication’s pKa values have an important role to play in 
their physicochemical data and they are also important in their biological activities. Various NMR 
reporter nuclei have been used to ascertain the individual pKa values that cannot be obtained by 
potentiometric methods, particularly the order in which the amino functional groups either gain or 
shed protons. These data have the capacity to enhance comprehension of the order of target mRNA 
binding of the basic functional groups. 
Materials and methods 
Aminoglycoside analyte solutions (0.15-0.73 M aminoglycoside in 99.97% D2O) were prepared at a 
~10 mg/mL concentration. NMR spectra including:  1H, 13C, HSQC, HMBC, NOESY, and 15N-
HMBC were recorded on Bruker Avance III 400 and 500 MHz spectrometers. 
Trimethylsilylpropanoic acid (TMSP) was used as a reference at 0.00 ppm for 1H and 13C NMR 
spectroscopies. 15N chemical shift values were measured relative to external CH3NO2 set at -511.72 
ppm. The pH values were adjusted using 0.5 M NaOD/DCl. MestReNova was used for analysis of the 
recorded spectra. The nonlinear sigmoidal curve and the inflection point of the sigmoidal curve were 
determined using GraphPad Prism 7 (Version 2017) after subtraction of 0.5 to convert the measured 
pD values into pH values (Popov et al., 2006). 
Results 
The pKa values of 1-NH2 and 3-NH2 of 2-deoxystreptamine are 9.26 and 7.00. The order of ionisation 
constants for neamine is: N-6' (8.31) > N-1 (7.60) > N-2' (7.11) > N-3 (6.50), for neomycin is:  N-6''' 
(8.76) > N-6' (8.65) > N-1 (8.08) ≈ N-2' (7.98) ≈ N-2''' (8.03) > N-3 (6.86), for tobramycin is:  N-6' 
(9.10) > N-2' (7.75) ≈ N-3'' (7.68) > N-1 (7.55) > N-3 (6.70) and for sisomicin is:  N-6' (9.30) > N-3'' 
(8.50) > N-2' (8.00) > N-1 (7.42) > N-3 (6.22). 
Conclusions 
1H, 13C, and 15N NMR spectroscopies are powerful techniques when it comes to measuring distinct 
pKa values. Also, owing to its sensitivity, 1H NMR spectroscopy requires less time, taking only two 
minutes for each sample, in comparison to 13C which requires 30 minutes for each sample, and 15N-
HMBC, requiring 45 minutes per sample. Unambiguous assignments have been made for each amine 
on these clinically significant aminoglycoside antibiotics. 
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The biological activities of these natural product alkaloid aminoglycoside antibiotics depend upon 
the amino functional group substituents located around the various rings. The ionisation constant (pKa) is 
the pH at which functional groups are 50% ionized. Any medication’s pKa values have an important role to 
play in their physicochemical data and they are also important in the biological activities of drugs. Various 
NMR reporter nuclei have been used to ascertain the individual pKa values that cannot be obtained 
through the use of potentiometric methods, particularly the order in which the functional groups either 
gain or shed protons. These data have the capacity to enhance comprehension of the order of target 
mRNA binding of the basic functional groups. The aim is to measure the pKa values of individual amines 
on selected aminoglycoside alkaloids from Streptomyces and Micromonospora by using new 
combinations of 1H, 13C, and 15N NMR spectroscopic data. 
Aminoglycoside analyte solutions (0.15-0.73 M aminoglycoside in 99.97% D2O) were prepared at a 
~10 mg/mL concentration. NMR spectra including 1H, 13C, HSQC, HMBC, NOESY, and 15N-HMBC were 
recorded on Bruker Avance III 400 and 500 MHz spectrometers. Trimethylsilylpropanoic acid (TMSP) was 
used as a reference at 0.00 ppm for 1H and 13C NMR spectroscopies. 15N chemical shift values were 
measured relative to external CH3NO2 set at -511.72 ppm. The pH values were adjusted using 0.5 M 
NaOD/DCl. MestReNova was used for analysis of the recorded spectra. The nonlinear sigmoidal curve and 
the inflection point of the sigmoidal curve were determined using GraphPad Prism 7 (Version 2017), after 
subtraction of 0.5 to convert the measured pD values into pH values.[1] 
The pKa values of 1-NH2 and 3-NH2 of 2-deoxystreptamine are 9.26 and 7.00. The order of ionisation 
constants for neamine is: N-6' (8.31) > N-1 (7.60) > N-2' (7.11) > N-3 (6.50), for neomycin is:  N-6''' (8.76) > 
N-6' (8.65) > N-1 (8.08) ≈ N-2' (7.98) ≈ N-2''' (8.03) > N-3 (6.86), for tobramycin is:  N-6' (9.10) > N-2' (7.75) 
≈ N-3'' (7.68) > N-1 (7.55) > N-3 (6.70) and for sisomicin is:  N-6' (9.30) > N-3'' (8.50) > N-2' (8.00) > N-1 
(7.42) > N-3 (6.22) (Fig. 1).  
In conclusion, 1H, 13C, and 15N NMR spectroscopies are powerful techniques when it comes to 
measuring distinct pKa values. Also, owing to of its sensitivity, 1H NMR spectroscopy requires less time, 
taking only two minutes for each sample, in comparison to 13C which requires 30 minutes for each 
sample, and 15N-HMBC, requiring 45 minutes per sample. Unambiguous assignments have been made for 




Fig. 1. The pKa values of each individual amine on aminoglycosides determined using 1H (red), 13C (blue), and 15N-HMBC 
(black) NMR spectroscopies. 
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Table 4.6a The 1H chemical shifts (ppm) (500 MHz) of H-1/3, H-2ax, H-2eq, H-4/6, and H-5 
of 0.245-0.105 M 2-deoxystreptamine were measured relative to TMSP in 99.97% D2O at 
25°C at different pHs 
pH H-1/3 H-2ax H-2eq H-4/6 H-5 
1.78 3.36 1.85 2.48 3.56 3.45 
2.94  3.36 1.85 2.48 3.56 3.45 
4.28 3.36 1.85 2.48 3.56 3.45 
4.85 3.36 1.85 2.47 3.56 3.45 
6.42 3.34 1.82 2.48 3.56 3.49 
7.08 3.24 1.79 2.38 3.49 3.41 
7.94 3.16 1.65 2.34 3.43 3.41 
8.52 3.16 1.63 2.32 3.42 3.40 
8.75 3.13 1.56 2.29 3.41 3.38 
9.19 3.03 1.53 2.27 3.39 3.35 
9.68 2.92 1.40 2.11 3.29 3.29 
10.01 2.74 1.21 2.00 3.14 3.26 










Table 4.6b The 1H chemical shifts (ppm) (500 MHz) of H-1/3, H-2ax, H-2eq, H-4/6, and H-
5 of 0.242-0.118 M 2-deoxystreptamine were measured relative to TMSP in 99.97% D2O at 
25°C at different pHs 
pH H-1/3 H-2ax H-2eq H-4/6 H-5 
1.49 3.35 1.85 2.46 3.55 3.42 
2.80 3.35 1.84 2.46 3.55 3.42 
4.00 3.36 1.84 2.46 3.55 3.42 
4.75 3.35 1.84 2.46 3.54 3.42 
6.32 3.35 1.82 2.45 3.50 3.39 
6.91 3.21 1.78 2.35 3.41 3.39 
7.89 3.09 1.58 2.29 3.41 3.35 
8.50 3.10 1.55 2.26 3.42 3.32 
8.64 3.08 1.52 2.22 3.40 3.30 
9.08 2.91 1.40 1.99 3.30 3.32 
9.50 2.77 1.30 1.81 3.14 3.23 
10.12 2.73 1.25 1.80 3.13 3.21 











Table 4.6c The 1H chemical shifts (ppm) (500 MHz) of H-1/3, H-2ax, H-2eq, H-4/6, and H-5 
of 0.244-0.110 M 2-deoxystreptamine were measured relative to TMSP in 99.97% D2O at 
25°C at different pHs 
pH H-1/3 H-2ax H-2eq H-4/6 H-5 
1.71 3.37 1.85 2.47 3.55 3.42 
2.90 3.36 1.85 2.47 3.55 3.42 
4.20 3.37 1.84 2.47 3.54 3.42 
4.83 3.36 1.84 2.47 3.54 3.42 
6.04 3.33 1.81 2.47 3.52 3.40 
6.93 3.22 1.79 2.37 3.45 3.40 
7.90 3.12 1.49 2.33 3.42 3.40 
8.42 3.12 1.50 2.30 3.43 3.37 
8.71 3.10 1.50 2.27 3.42 3.36 
9.15 3.08 1.44 1.99 3.31 3.34 
9.60 2.81 1.42 1.90 3.25 3.26 
10.02 2.75 1.20 1.90 3.13 3.24 











Table 4.6d The average of Tables 4.2a, b, and c 1H chemical shifts (ppm) (500 MHz) of H-
1/3, H-2ax, H-2eq, H-4/6, and H-5 of 0.243-0.111 M 2-deoxystreptamine were measured 
relative to TMSP in 99.97% D2O at 25°C at different pHs 
pH H-1/3 H-2ax H-2eq H-4/6 H-5 
1.66 ± 0.15 3.36 ± 0.01 1.85 ± 0.01 2.47 ± 0.01 3.55 ± 0.02 3.43 ± 0.02 
2.88 ± 0.07 3.36 ± 0.01 1.85 ± 0.02 2.47 ± 0.01 3.55 ± 0.02 3.43 ± 0.02 
4.16 ±0.14 3.36 ± 0.01 1.84 ± 0.02 2.47 ± 0.01 3.55 ± 0.01 3.43 ± 0.02 
4.81± 0.05 3.36 ± 0.01 1.84 ± 0.02 2.47 ± 0.01 3.55 ± 0.01 3.43 ± 0.02 
6.38 ± 0.20 3.34 ± 0.01 1.83 ± 0.02 2.46 ± 0.02 3.52 ± 0.03 3.42 ± 0.06 
6.97 ± 0.09 3.22 ± 0.02 1.79 ± 0.01 2.36 ± 0.02 3.45 ± 0.04 3.40 ± 0.01 
7.91 ± 0.03 3.12 ± 0.04 1.60 ± 0.08 2.32 ± 0.03 3.42 ± 0.01 3.38 ± 0.03 
8.48 ± 0.05 3.12 ± 0.03 1.55 ± 0.07 2.29 ± 0.03 3.42 ± 0.02 3.37 ± 0.04 
8.70 ± 0.06 3.10 ± 0.03 1.52 ± 0.03 2.26 ± 0.04 3.41 ± 0.01 3.35 ± 0.04 
9.14 ± 0.06 3.00 ± 0.09 1.45 ± 0.07 1.95 ± 0.10 3.33 ± 0.05 3.33 ± 0.02 
9.59 ± 0.09 2.83 ± 0.08 1.37 ± 0.06 1.94 ± 0.10 3.14 ± 0.08 3.26 ± 0.03 
10.05 ± 0.06 2.74 ± 0.01 1.22 ± 0.03 1.94 ± 0.10 3.13 ± 0.02 3.24 ± 0.03 












Table 4.7a The 13C chemical shifts (ppm) (125.77 MHz) of C-1/3, C-2, C-4/6, and C-5 of 
0.245-0.105 M 2-deoxystreptamine were measured relative to TMSP in 99.97% D2O at 25°C 
at different pHs 
pH C-1/3 C-2 C-4/6 C-5 
1.78 52.88 30.93  75.07 77.44 
2.94 52.88 30.93  75.07 77.44 
4.28 52.88  30.93 75.07 77.44 
4.85 52.88 30.93 75.07 77.44 
6.42 52.98 31.03  75.17 77.54 
7.08 53.17 33.72  77.00 77.85 
7.94 53.24 34.75 77.69 77.98 
8.52 53.26 35.31 78.09 78.09 
8.75 53.28 36.04 78.62 78.16 
9.19 53.30 37.26 79.47 78.32 
9.68 53.31 38.20 80.18 78.46 
10.01 53.32 38.83 80.84 78.53 












Table 4.7b The 13C chemical shifts (ppm) (125.77 MHz) of C-1/3, C-2, C-4/6, and C-5 of 
0.242-0.118 M 2-deoxystreptamine were measured relative to TMSP in 99.97% D2O at 25°C 
at different pHs 
pH C-1/3 C-2 C-4/6 C-5 
1.49 53.00 31.14 75.20 77.60 
2.80 53.00 31.14 75.22 77.61 
4.00 53.00 31.05 75.15 77.50 
4.75 53.00 31.05 75.15 77.51 
6.32 53.10 30.99 75.22 77.55 
6.91 52.94 31.81 75.55 77.68 
7.89 53.10 34.80 77.64 77.60 
8.50 53.18 37.52 79.20 78.30 
8.64 53.20 39.77 81.10 78.55 
9.08 53.19 39.00 80.02 78.60 
9.50 53.28 39.00 79.95 78.66 
10.12 53.29 38.81 79.77 78.63 













Table 4.7c The 13C chemical shifts (ppm) (125.77 MHz) of C-1/3, C-2, C-4/6, and C-5 of 
0.244-0.110 M 2-deoxystreptamine were measured relative to TMSP in 99.97% D2O at 25°C 
at different pHs 
pH C-1/3 C-2 C-4/6 C-5 
1.71 52.97 31.20 75.39 77.76 
2.90 52.97 31.19 75.41 77.76 
4.20 52.97 31.04 75.25 77.68 
4.83 52.97 31.04 75.25 77.64 
6.04 52.83 31.10 75.84 77.59 
6.93 52.95 32.00 76.02 77.68 
7.90 53.17 34.88 77.95 77.70 
8.42 53.22 37.93 80.43 78.48 
8.71 53.20 40.11 81.72 79.09 
9.15 53.20 40.00 82.18 78.73 
9.60 53.37 39.13 81.70 78.86 
10.02 53.35 38.81 81.22 78.64 












Table 4.7d The average of Tables 4.3a, b, and c 13C chemical shifts (ppm) (125.77 MHz) of 
C-1/3, C-2, C-4/6, and C-5 of 0.243-0.111 M 2-deoxystreptamine were measured relative to 
TMSP in 99.97% D2O at 25°C at different pHs 
pH C-1/3 C-2 C-4/6 C-5 
1.66 ± 0.15 52.95 ± 0.06 31.09 ± 0.14 75.21 ± 0.16 77.60 ± 0.16 
2.88 ± 0.07 52.95 ± 0.06 31.10 ± 0.14 75.23 ± 0.17 77.60 ± 0.16 
4.16 ± 0.14 52.95 ± 0.06 31.04 ± 0.07 75.16 ± 0.09 77.54 ± 0.12 
4.81 ± 0.05 52.95 ± 0.06 31.04 ± 0.07 75.16 ± 0.09 77.53 ± 0.10 
6.38 ± 0.20 52.97 ± 0.14 31.04 ± 0.06 75.41 ± 0.37 77.56 ± 0.03 
6.97 ± 0.09 53.02 ± 0.13 32.51 ± 1.05 76.19 ± 0.74 77.74 ± 0.10 
7.91 ± 0.03 53.17 ± 0.07 34.81 ± 0.07 77.76 ± 0.17 77.76 ± 0.20 
8.48 ± 0.05 53.22 ± 0.04 36.93 ± 1.41 79.24 ± 1.17 78.29 ± 0.20 
8.70 ± 0.06 53.23 ± 0.05 38.64 ± 1.26 80.48 ± 1.64 78.60 ± 0.47 
9.14 ± 0.06 53.23 ± 0.06 38.76 ± 1.39 80.55 ± 1.43 78.55 ± 0.21 
9.58 ± 0.09 53.32 ± 0.05 38.82 ± 0.50 80.61 ± 0.95 78.60 ± 0.20 
10.05 ± 0.06 53.32 ± 0.03 38.82 ± 0.01 80.61 ± 0.75 78.60 ± 0.06 













Table 4.8a The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1/3 of 0.633-0.370 M 2-



























Table 4.8b The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1/3 of 0.631-0.369 M 2-




























Table 4.8c The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1/3 of 0.630-0.368 M  


























Table 4.8d The average of Tables 4.4a, b, and c 15N HMBC chemical shifts (ppm) (50.67 
MHz) of N-1/3 of 0.631-0.369 M 2-deoxystreptamine were measured relative to CH3NO2 in 
99.97% D2O at 25°C at different pHs 
pH N-1/3 
1.55 ± 0.02 48.17 ± 0.01 
3.75 ± 0.02 48.17 ± 0.01 
4.54 ± 0.08 48.17 ± 0.01 
5.54 ± 0.04 48.09 ± 0.03 
6.04 ± 0.15 47.80 ± 0.08 
6.58 ± 0.05 47.08 ± 0.12 
7.05 ± 0.05 46.02 ± 0.03 
7.72 ± 0.08 44.41 ± 0.20 
8.03 ± 0.17 44.40 ± 0.20 
8.68 ± 0.10 42.90 ± 0.14 
9.33 ± 0.20 41.45 ± 0.05 
10.00 ± 0.12 40.84 ± 0.03 
11.30 ± 0.20 40.45 ± 0.01 












Table 4.10 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, and H-6'b of 
0.243-0.155 M neamine were measured relative to TMSP in 99.97% D2O at 25°C at different 
pHs 
pH H-1 H-3 H-2' H-6'a H-6'b 
3.10 ± 0.10 3.37 ± 0.03 3.55 ± 0.04 3.46 ± 0.03 3.31 ± 0.02 3.49 ± 0.04 
3.99 ± 0.08 3.37 ± 0.03 3.55 ± 0.04 3.46 ± 0.03 3.31 ± 0.02 3.49 ± 0.04 
4.50 ± 0.06 3.37 ± 0.03 3.55 ± 0.04 3.46 ± 0.03 3.31 ± 0.03 3.49 ± 0.03 
5.06 ± 0.06 3.36 ± 0.04 3.52 ± 0.04 3.46 ± 0.03 3.31 ± 0.02 3.49 ± 0.04 
5.47 ± 0.07 3.34 ± 0.05 3.46 ± 0.06 3.44 ± 0.05 3.29 ± 0.04 3.48 ± 0.06 
5.73 ± 0.08 3.31 ± 0.06 3.37 ± 0.06 3.41 ± 0.05 3.28 ± 0.04 3.47 ± 0.05 
6.03 ± 0.10 3.30 ± 0.06 3.31 ± 0.05 3.39 ± 0.06 3.27 ± 0.05 3.46 ± 0.05 
6.45 ± 0.15 3.25 ± 0.05 3.19 ± 0.04 3.30 ± 0.05 3.24 ± 0.05 3.45 ± 0.06 
7.01 ± 0.09 3.20 ± 0.05 3.12 ± 0.05 3.16 ± 0.06 3.22 ± 0.04 3.44 ± 0.06 
7.62 ± 0.08 3.12 ± 0.04 3.05 ± 0.05 3.00 ± 0.06 3.18 ± 0.06 3.40 ± 0.04 
8.04 ± 0.09 2.99 ± 0.04 3.00 ± 0.04 2.91 ± 0.05 3.13 ± 0.05 3.34 ± 0.06 
8.55 ± 0.07 2.90 ± 0.05 2.96 ± 0.06 2.86 ± 0.06 3.04 ± 0.05 3.25 ± 0.06 
8.67 ± 0.06 2.85 ± 0.03 2.94 ± 0.04 2.84 ± 0.05 2.99 ± 0.05 3.21 ± 0.06 
8.91 ± 0.05 2.80 ± 0.03 2.91 ± 0.05 2.83 ± 0.04 2.93 ± 0.05 3.15 ± 0.04 
9.26 ± 0.04 2.75 ± 0.05 2.89 ± 0.05 2.82 ± 0.03 2.89 ± 0.04 3.07 ± 0.05 
9.45 ± 0.06 2.72 ± 0.03 2.87 ± 0.03 2.81 ± 0.02 2.84 ± 0.03 3.05 ± 0.05 
9.60 ± 0.10 2.72 ± 0.03 2.87 ± 0.03 2.81 ± 0.02 2.82 ± 0.02 3.04 ± 0.03 
10.67 ± 0.08 2.72 ± 0.03 2.87 ± 0.03 2.81 ± 0.02 2.82 ± 0.02 3.04 ± 0.03 






Table 4.11 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', and C-6' of 0.243-
0.155 M neamine were measured relative to TMSP in 99.97% D2O at 25°C at different pHs 
pH C-1 C-3 C-2' C-6' 
3.10 ± 0.10 52.52 ± 0.02 51.08 ± 0.03 56.25 ± 0.04 42.78 ± 0.04 
3.99 ± 0.08 52.52 ± 0.02 51.08 ± 0.03 56.22 ± 0.03 42.78 ± 0.03 
4.50 ± 0.06 52.52 ± 0.03 51.08 ± 0.03 56.22 ± 0.03 42.78 ± 0.04 
5.06 ± 0.06 52.52 ± 0.02 51.08 ± 0.02 56.25 ± 0.04 42.78 ± 0.03 
5.47 ± 0.07 52.54 ± 0.04 51.08 ± 0.04 56.35 ± 0.06 42.82 ± 0.05 
5.73 ± 0.08 52.55 ± 0.04 51.15 ± 0.04 56.43 ± 0.05 42.93 ± 0.06 
6.03 ± 0.10 52.57 ± 0.05 51.20 ± 0.05 56.53 ± 0.05 42.96 ± 0.05 
6.45 ± 0.15 52.59 ± 0.05 51.55 ± 0.06 56.72 ± 0.06 43.02 ± 0.04 
7.01 ± 0.09 52.81 ± 0.04 52.09 ± 0.03 57.32 ± 0.06 43.31 ± 0.07 
7.62 ± 0.08 52.89 ± 0.06 52.18 ± 0.06 57.52 ± 0.04 43.44 ± 0.05 
8.04 ± 0.09 53.11 ± 0.05 52.18 ± 0.05 57.74 ± 0.06 43.73 ± 0.04 
8.55 ± 0.07 53.13± 0.05 52.18 ± 0.07 57.78 ± 0.06 43.7 9± 0.04 
8.67 ± 0.06 53.13 ± 0.05 52.19 ± 0.05 57.83 ± 0.07 44.01 ± 0.04 
8.91 ± 0.05 53.13 ± 0.05 52.19 ± 0.05 57.95 ± 0.04 44.14 ± 0.05 
9.26 ± 0.04 53.13 ± 0.04 52.19 ± 0.04 58.00 ± 0.04 44.38 ± 0.06 
9.45 ± 0.06 53.13 ± 0.03 52.19 ± 0.03 58.01 ± 0.03 44.41 ± 0.04 
9.60 ± 0.10 53.13 ± 0.02 52.19 ± 0.04 58.04 ± 0.03 44.40 ± 0.04 
10.67 ± 0.08 53.13 ± 0.02 52.19 ± 0.04 58.04 ± 0.03 44.40 ± 0.04 









Table 4.12 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', and N-6' of 
0.243-0.155 M neamine were measured relative to CH3NO2 in 99.97% D2O at 25°C at different 
pHs 
pH N-1 N-3 N-2' N-6' 
3.07 ± 0.015 48.01 ± 0.06 49.05 ± 0.04 43.91 ± 0.04 36.24 ± 0.07 
4.04 ± 0.09 48.04 ± 0.05 49.07 ± 0.03 43.91 ± 0.04 36.25 ± 0.07 
5.03 ± 0.15 47.92 ± 0.05 49.07 ± 0.08 43.82 ± 0.05 36.25 ± 0.06 
5.82 ± 0.10 47.73 ± 0.04 47.1 5 ± 0.06 42.99 ± 0.06 36.11 ± 0.08 
7.00 ± 0.15 45.22 ± 0.04 43.51 ± 0.07 39.03 ± 0.15 33.89 ± 0.08 
8.03 ± 0.09 43.11 ± 0.15 42.55 ± 0.09 33.04 ± 0.07 31.02 ± 0.09 
8.64 ± 0.10 41.55 ± 0.04 42.05 ± 0.02 32.01 ± 0.08 29.92 ± 0.08 
9.15 ± 0.15 40.73 ± 0.06 41.51 ± 0.04 31.82 ± 0.07 28.78 ± 0.10 
9.80 ± 0.10 40.18 ± 0.04 41.42 ± 0.07 31.56 ± 0.07 26.75 ± 0.04 
10.52 ± 0.08 40.1 5± 0.05 41.31 ± 0.06 31.22 ± 0.04 25.65 ± 0.04 













Table 4.14 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b, H-2''', 
H-6'''a, and H-6'''b of 0.218-0.122 M neomycin C were measured relative to TMSP in 99.97% 
D2O at 25°C at different pHs 




























































































































































































































Table 4.15 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', C-6', C-2''', and C-
6''' of 0.218-0.122 M neomycin C were measured relative to TMSP in 99.97% D2O at 25°C at 
different pHs 













































































































































































Table 4.16 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', N-6', N-2''', 
and N-6''' of 0.392-0.218 M neomycin C were measured relative to CH3NO2 in 99.97% D2O 
at 25°C at different pHs 













































































































































































Table 4.18 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-2''', H-6'''a, and H-
6'''b of 0.335-0.208 M paromomycin were measured relative to TMSP in 99.97% D2O at 25°C 
at different pHs 
pH H-1 H-3 H-2' H-2''' H-6'''a H-6'''b 
1.51 3.36 3.58 3.45 3.65 3.44 3.44 
4.01 3.36 3.56 3.44 3.65 3.43 3.43 
4.83 3.37 3.56 3.44 3.65 3.44 3.44 
6.01 3.39 3.55 3.44 3.64 3.43 3.43 
7.01 3.31 3.31 3.35 3.58 3.41 3.41 
7.95 3.13 3.07 3.11 3.35 3.36 3.36 
8.57 2.96 2.97 2.91 3.16 3.27 3.27 
9.75 2.73 2.88 2.75 3.03 2.94 3.04 
11.25 2.73 2.86 2.72 3.01 2.82 2.93 
 
Table 4.19 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', C-2''', and C-6''' of 
0.335-0.208 M paromomycin were measured relative to TMSP in 99.97% D2O at 25°C  
pH C-1 C-3 C-2' C-2''' C-6''' 
1.51 49.67 48.78 53.78 50.63 40.41 
4.01 49.68 48.91 53.78 50.63 40.41 
4.83 49.91 48.85 53.99 50.71 40.49 
6.01 50.21 48.85 53.99 50.77 40.44 
7.01 50.43 51.21 54.72 51.46 40.44 
7.95 50.81 52.77 56.28 52.11 41.09 
8.57 52.81 53.01 57.81 54.79 41.44 
9.75 52.93 52.93 58.15 55.31 43.69 




Table 4.20 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', N-2''', and 
N-6''' of 0.335-0.208 M paromomycin were measured relative to CH3NO2 in 99.97% D2O at 
25°C at different pHs 
pH N-1 N-3 N-2' N-2''' N-6''' 
1.51 47.31 49.21 43.01 38.34 37.17 
4.01 47.31 49.21 43.01 38.33 37.17 
4.83 47.31 49.21 43.01 38.33 37.16 
6.01 47.14 47.81 43.41 38.69 35.98 
7.01 45.15 46.55 42.09 37.34 36.05 
7.95 45.15 41.28 38.49 32.39 35.51 
8.57 42.89 40.66 35.24 28.01 33.81 
9.75 42.01 40.19 32.64 25.19 25.33 















Table 4.22 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b, and H-
3'' of 0.251-0.132 M tobramycin were measured relative to TMSP in 99.97% D2O at 25°C at 
different pHs 
pH H-1 H-3 H-2' H-6'a H-6'b H-3'' 
2.61 ± 0.09 3.65 ± 0.01 3.60 ± 0.01 3.69 ± 0.01 3.32 ± 0.01 3.45 ± 0.01 3.52 ± 0.02 
4.09 ± 0.10 3.65 ± 0.02 3.60 ± 0.02 3.69 ± 0.02 3.33 ± 0.02 3.46 ± 0.02 3.53 ± 0.03 
4.50 ± 0.07 3.65 ± 0.03 3.60 ± 0.01 3.69 ± 0.03 3.33 ± 0.03 3.46 ± 0.03 3.53 ± 0.09 
5.85 ± 0.08 3.60 ± 0.04 3.48 ± 0.02 3.68 ± 0.01 3.33 ± 0.05 3.47 ± 0.07 3.53 ± 0.07 
6.37 ± 0.12 3.52 ± 0.07 3.34 ± 0.03 3.64 ± 0.07 3.33 ± 0.07 3.46 ± 0.02 3.50 ± 0.05 
7.24 ± 0.09 3.36 ± 0.02 3.16 ± 0.01 3.50 ± 0.05 3.30 ± 0.05 3.44 ± 0.03 3.37 ± 0.04 
7.51 ± 0.03 3.31 ± 0.03 3.11 ± 0.02 3.40 ± 0.04 3.31 ± 0.04 3.44 ± 0.09 3.32 ± 0.08 
7.81 ± 0.10 3.22 ± 0.04 3.08 ± 0.03 3.31 ± 0.01 3.28 ± 0.01 3.42 ± 0.07 3.20 ± 0.02 
8.57 ± 0.03 3.10 ± 0.06 3.02 ± 0.01 3.13 ± 0.02 3.20 ± 0.02 3.34 ± 0.05 3.09 ± 0.03 
9.15 ± 0.07 2.98 ± 0.05 2.95 ± 0.02 3.07 ± 0.03 3.08 ± 0.03 3.21 ± 0.04 3.05 ± 0.04 
9.53 ± 0.08 2.94 ± 0.04 2.91 ± 0.01 3.01 ± 0.08 2.98 ± 0.07 3.11 ± 0.08 3.02 ± 0.02 
10.21 ± 0.05 2.91 ± 0.02 2.88 ± 0.02 2.96 ± 0.07 2.87 ± 0.07 3.00 ± 0.02 3.01 ± 0.02 
11.25 ± 0.10 2.90 ± 0.05 2.88 ± 0.03 2.96 ± 0.01 2.84 ± 0.05 2.97 ± 0.03 3.01 ± 0.03 
11.95 ± 0.03 2.90 ± 0.02 2.88 ± 0.01 2.95 ± 0.02 2.84 ± 0.04 2.97 ± 0.04 3.00 ± 0.04 











Table 4.23 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', C-6', and C-3'' of 
0.251-0.132 M tobramycin were measured relative to TMSP in 99.97% D2O at 25°C at 
different pHs 
pH C-1 C-3 C-2' C-6' C-3'' 
2.61 ± 0.09 50.61 ± 0.01 52.51 ± 0.02 51.21 ± 0.01 42.91 ± 0.02 56.99 ± 0.02 
4.09 ± 0.10 50.59 ± 0.02 52.51 ± 0.03 51.21 ± 0.02 42.91 ± 0.03 56.98 ± 0.05 
4.50 ± 0.07 50.58 ± 0.04 52.51 ± 0.09 51.19 ± 0.03 42.89 ± 0.09 56.97 ± 0.02 
5.85 ± 0.08 50.71 ± 0.02 52.56 ± 0.02 51.34 ± 0.05 43.01 ± 0.07 56.97 ± 0.01 
6.37 ± 0.12 50.84 ± 0.05 52.67 ± 0.03 51.42 ± 0.07 43.04 ± 0.05 56.96 ± 0.10 
7.24 ± 0.09 51.11 ± 0.07 52.97 ± 0.09 51.57 ± 0.05 43.05 ± 0.04 57.01 ± 0.03 
7.51 ± 0.03 51.19 ± 0.01 53.05 ± 0.07 51.74 ± 0.04 43.09 ± 0.08 57.12 ± 0.03 
7.81 ± 0.10 51.39 ± 0.10 53.06 ± 0.05 51.81 ± 0.01 43.11 ± 0.02 57.41 ± 0.07 
8.57 ± 0.03 51.55 ± 0.03 53.07 ± 0.04 51.92 ± 0.02 43.34 ± 0.02 57.52 ± 0.05 
9.15 ± 0.07 51.63 ± 0.06 53.07 ± 0.08 52.07 ± 0.03 43.65 ± 0.03 57.61 ± 0.02 
9.53 ± 0.08 51.77 ± 0.02 53.06 ± 0.02 52.15 ± 0.07 43.92 ± 0.09 57.64 ± 0.01 
10.21 ± 0.05 51.94 ± 0.01 53.06 ± 0.03 52.26 ± 0.07 44.32 ± 0.07 57.68 ± 0.10 
11.25 ± 0.10 51.97 ± 0.03 53.07 ± 0.04 52.29 ± 0.05 44.38 ± 0.05 57.69 ± 0.03 
11.95 ± 0.03 51.95 ± 0.07 53.08 ± 0.02 52.31 ± 0.04 44.43 ± 0.04 57.69 ± 0.03 













Table 4.24 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', N-6', and 
N-3'' of 0.740-0.370 M tobramycin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
at different pHs 
pH N-1 N-3 N-2' N-6' N-3'' 
1.61 ± 0.09 47.71 ± 0.02 49.27 ± 0.03 48.19 ± 0.03 36.74 ± 0.05 42.83 ± 0.02 
2.55 ± 0.13 47.71± 0.05 49.26 ± 0.06 48.19 ± 0.09 36.74 ± 0.04 42.83 ± 0.04 
3.85 ± 0.07 47.68 ± 0.02 49.22 ± 0.02 48.20 ± 0.07 36.75 ± 0.01 42.82 ± 0.06 
5.07 ± 0.08 47.20 ± 0.01 48.81 ± 0.02 48.20 ± 0.05 36.61 ± 0.05 42.51 ± 0.07 
5.71 ± 0.12 46.91 ± 0.10 48.06 ± 0.07 48.13 ± 0.03 36.44 ± 0.04 42.38 ± 0.10 
6.02 ± 0.18 46.51 ± 0.03 47.51 ± 0.06 47.71 ± 0.09 36.31 ± 0.01 42.35 ± 0.12 
7.03 ± 0.09 44.51 ± 0.03 44.43 ± 0.02 44.94 ± 0.03 35.53 ± 0.02 40.54 ± 0.05 
7.75 ± 0.17 43.01 ± 0.02 43.59 ± 0.04 43.69 ± 0.03 34.97 ± 0.03 38.01 ± 0.05 
8.38 ± 0.08 42.05 ± 0.02 42.81 ± 0.03 42.42 ± 0.02 33.68 ± 0.07 36.43 ± 0.02 
8.71 ± 0.12 41.72 ± 0.05 42.55 ± 0.07 41.71 ± 0.02 32.82 ± 0.05 35.53 ± 0.03 
9.50 ± 0.05 40.83 ± 0.02 41.87 ± 0.01 40.03 ± 0.05 27.35 ± 0.04 33.97 ± 0.01 
10.09 ± 0.07 40.55 ± 0.01 41.42 ± 0.02 39.42 ± 0.02 24.91 ± 0.01 33.47 ± 0.01 
11.34 ± 0.10 40.21 ± 0.10 41.21 ± 0.04 39.41 ± 0.01 23.71 ± 0.02 33.31 ± 0.03 












Table 4.26 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b and H-
3'' of 1.315-0.822 M kanamycin B were measured relative to TMSP in 99.97% D2O at 25°C 
at different pHs 
pH H-1 H-3 H-2' H-6'a H-6'b H-3'' 
1.51 3.59 3.66 3.53 3.53 3.26 3.44 
4.92 3.59 3.66 3.53 3.53 3.26 3.44 
5.54 3.55 3.66 3.50 3.54 3.28 3.41 
6.54 3.41 3.35 3.39 3.51 3.25 3.31 
7.01 3.45 3.19 3.25 3.48 3.25 3.27 
8.27 3.17 2.89 3.01 3.38 3.16 3.03 
9.05 2.97 2.89 2.91 3.19 2.99 2.79 
10.51 2.91 2.89 2.84 2.99 2.89 2.75 
11.10 2.87 2.88 2.81 2.99 2.81 2.75 
11.51 2.87 2.88 2.81 2.99 2.81 2.75 
 
Table 4.27 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', C-6', and C-3'' of 
1.315-0.822 M kanamycin B were measured relative to TMSP in 99.97% D2O at 25°C at 
different pHs 
pH C-1 C-3 C-2' C-6' C-3'' 
1.51 51.06 52.28 57.58 43.14 56.33 
4.92 51.09 52.28 57.59 43.16 56.34 
5.54 51.04 52.29 57.57 43.16 56.32 
6.54 51.27 52.31 57.67 43.21 56.57 
7.01 51.31 52.49 57.8 43.22 56.56 
8.27 52.51 52.55 58.2 43.23 57.57 
9.05 53.49 52.55 58.29 43.74 57.81 
10.51 53.51 52.58 58.31 44.41 57.99 
11.10 53.55 52.58 58.32 44.51 58.01 




Table 4.28 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', N-6', and 
N-3'' of 1.315-0.822 M kanamycin B were measured relative to CH3NO2 in 99.97% D2O at 
25°C at different pHs 
pH N-1 N-3 N-2' N-6' N-3'' 
1.51 47.21 48.22 43.14 36.01 42.43 
4.92 47.22 48.25 43.14 35.01 42.47 
5.54 46.77 47.19 42.69 35.72 42.52 
6.54 46.32 46.32 40.61 35.66 42.04 
7.01 45.57 44.85 37.81 35.51 41.37 
8.27 43.33 43.63 34.15 35.17 35.61 
9.05 41.33 42.44 34.03 29.72 34.47 
10.51 41.25 42.35 31.74 28.55 33.99 
11.10 41.03 42.09 31.51 27.68 33.82 
11.51 41.03 42.09 31.51 27.68 33.82 
 
Table 4.30 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b, and H-
3'' of 0.506-0.434 M netilmicin were measured relative to TMSP in 99.97% D2O at 25°C at 
different pHs 
pH H-1 H-3 H-2' H-6'a H-6'b H-3'' 
2.05 3.57 3.55 3.93 3.34 3.14 3.52 
5.18 3.56 3.55 3.92 3.35 3.13 3.51 
6.77 3.47 3.11 3.84 3.31 3.09 3.49 
7.52 3.35 2.88 3.75 3.30 3.05 3.39 
8.11 3.18 2.81 3.63 3.20 2.95 3.21 
9.51 2.76 2.76 3.34 3.01 2.77 2.59 
10.41 2.74 2.73 3.33 2.71 2.45 2.57 




Table 4.31 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', C-6', and C-3'' of 
0.506-0.434 M netilmicin were measured relative to TMSP in 99.97% D2O at 25°C at different 
pHs 
pH C-1 C-3 C-2' C-6' C-3'' 
2.05 58.74 50.73 85.32 43.09 66.33 
5.18 58.8 50.71 85.64 43.08 66.36 
6.77 59.09 51.58 86.02 43.10 66.37 
7.52 59.23 52.05 86.53 43.23 66.39 
8.11 59.58 52.05 87.01 43.30 66.41 
9.51 60.19 52.01 88.38 43.51 66.52 
10.41 60.25 52.05 88.44 43.83 66.56 
11.51 60.25 52.13 88.45 43.86 66.57 
 
Table 4.32 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', N-6', and 
N-3'' of 0.506-0.434 M netilmicin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
at different pHs 
pH N-1 N-3 N-2' N-6' N-3'' 
2.05 59.81 47.87 42.25 39.50 42.61 
5.18 59.81 47.82 42.25 39.45 42.57 
6.77 59.44 42.81 42.22 39.82 42.51 
7.52 59.31 41.01 40.78 38.77 41.71 
8.11 58.77 40.83 40.09 38.89 39.51 
9.51 57.42 40.31 31.82 33.33 31.82 
10.41 57.35 40.03 31.41 28.81 31.35 




Table 4.34 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3, H-2', H-6'a, H-6'b, and H-
3'' of 0.083-0.063 M sisomicin were measured relative to TMSP in 99.97% D2O at 25°C at 
different pHs 
pH H-1 H-3 H-2' H-6'a H-6'b H-3'' 
2.35 3.56 3.58 3.95 3.71 3.71 3.51 
4.12 3.56 3.58 3.95 3.71 3.71 3.51 
5.18 3.56 3.56 3.95 3.71 3.71 3.51 
5.56 3.56 3.50 3.95 3.71 3.71 3.51 
5.92 3.54 3.41 3.95 3.70 3.70 3.50 
6.51 3.47 3.13 3.91 3.70 3.70 3.48 
7.11 3.34 3.05 3.82 3.68 3.68 3.43 
7.51 3.19 3.00 3.73 3.66 3.66 3.39 
8.06 3.08 2.98 3.42 3.63 3.63 3.21 
8.51 2.99 2.95 3.34 3.58 3.58 3.05 
9.01 2.89 2.93 3.22 3.50 3.50 2.83 
9.57 2.81 2.91 3.13 3.29 3.29 2.65 
10.01 2.78 2.90 3.09 3.21 3.21 2.61 
10.65 2.76 2.90 3.07 3.15 3.15 2.57 
11.31 2.76 2.90 3.07 3.14 3.14 2.57 








Table 4.35 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3, C-2', C-6', and C-3'' of 
0.083-0.063 M sisomicin were measured relative to TMSP in 99.97% D2O at 25°C at different 
pHs 
pH C-1 C-3 C-2' C-6' C-3'' 
2.35 50.99 52.71 48.76 43.38 66.16 
4.12 51.01 52.71 48.76 43.38 66.16 
5.18 51.01 52.75 48.76 43.39 66.17 
5.56 51.01 52.95 48.76 43.39 66.18 
5.92 51.03 53.15 48.77 43.41 66.19 
6.51 51.06 53.30 48.80 43.42 66.29 
7.11 51.15 53.41 48.85 43.41 66.36 
7.51 51.23 53.48 48.94 43.45 66.41 
8.06 51.69 53.54 49.08 43.56 66.48 
8.51 51.85 53.59 49.16 43.81 66.51 
9.01 51.93 53.63 49.19 44.21 66.58 
9.57 52.09 53.68 49.25 44.65 66.69 
10.01 52.11 53.68 49.29 44.98 66.77 
10.65 52.16 53.69 49.35 45.20 66.88 
11.31 52.14 53.69 49.38 45.25 66.88 










Table 4.36 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3, N-2', N-6', and 
N-3'' of 0.160-0.112 M sisomicin were measured relative to CH3NO2 in 99.97% D2O at 25°C 
at different pHs 
pH N-1 N-3 N-2' N-6' N-3'' 
2.00 46.99 47.49 44.41 40.24 42.47 
3.48 46.98 47.47 44.41 40.24 42.46 
4.11 46.97 47.20 44.37 40.23 42.62 
5.05 46.76 46.51 43.18 39.73 42.37 
5.90 46.64 45.15 42.70 39.67 42.30 
7.20 44.69 42.52 41.99 40.11 42.12 
7.80 42.12 41.80 40.61 39.61 39.05 
8.91 40.51 41.01 35.12 37.21 35.39 
9.55 40.38 41.82 34.01 33.10 32.83 
10.52 40.53 41.16 32.80 29.47 31.07 
11.21 40.49 41.15 32.77 29.46 31.05 












Table 4.38 The 1H chemical shifts (ppm) (500 MHz) of H-3, H-6'a, H-6'b, H-3'', H-4'''a and 
H-4'''b of 0.896-0.597 M amikacin were measured relative to TMSP in 99.97% D2O at 25°C 
at different pHs 
pH H-3 H-6'a H-6'b H-3'' H-4'''a H-4'''b 
3.91 3.58 3.49 3.21 3.43 3.22 3.22 
5.58 3.57 3.49 3.19 3.42 3.19 3.19 
6.51 3.52 3.48 3.19 3.42 3.19 3.19 
7.03 3.47 3.47 3.18 3.38 3.17 3.17 
7.63 3.27 3.44 3.18 3.31 3.18 3.18 
8.13 3.09 3.38 3.13 3.16 3.18 3.18 
9.61 2.95 3.07 2.84 2.98 3.03 3.03 
10.08 2.94 3.01 2.81 2.98 2.92 2.92 
11.37 2.93 2.98 2.76 2.98 2.74 2.74 















Table 4.39 The 13C chemical shifts (ppm) (125.77 MHz) of C-3, C-6', C-3'', and C-4''' of 0.896-
0.597 M amikacin were measured relative to TMSP in 99.97% D2O at 25°C at different pHs 
pH C-3 C-6' C-3'' C-4''' 
3.91 50.67 42.01 56.7 39.51 
5.58 50.68 42.01 56.71 39.51 
6.51 50.71 42.09 56.76 39.51 
7.03 50.83 42.22 56.88 39.52 
7.63 50.99 42.44 57.18 39.55 
8.13 51.07 42.74 57.45 39.58 
9.61 51.31 43.76 57.81 39.77 
10.08 51.37 44.26 57.85 39.88 
11.37 51.37 44.43 57.91 40.09 
12.02 51.37 44.44 57.91 40.11 
 
Table 4.40 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-3, N-6', N-3'', and N-4''' of 0.896-
0.597 M amikacin were measured relative to CH3NO2 in 99.97% D2O at 25°C at different pHs 
pH N-3 N -6' N -3'' N -4''' 
3.91 47.66 35.64 42.56 41.81 
5.58 47.81 35.63 42.51 41.51 
6.51 47.12 35.72 42.01 41.75 
7.03 46.73 35.63 41.84 41.48 
7.63 44.31 35.11 40.41 41.51 
8.13 42.69 34.02 37.73 41.43 
9.61 41.41 25.01 33.82 38.81 
10.08 41.65 24.53 33.72 36.49 
11.37 41.07 23.82 33.58 32.01 




Table 4.42 The 1H chemical shifts (ppm) (500 MHz) of H-1, H-3 and H-2' of 0.738-0.527 M 
streptomycin were measured relative to TMSP in 99.97% D2O at 25°C at different pHs 
pH H-1 H-3 H-2' 
4.61 3.62 3.51 3.32 
5.71 3.62 3.51 3.32 
8.07 3.62 3.51 3.04 
10.35 3.62 3.51 2.58 
11.15 3.61 3.48 2.57 
11.72 3.59 3.44 2.55 
12.22 3.55 3.21 2.55 
13.51 3.11 3.12 2.55 
14.11 2.89 3.12 2.55 
 
Table 4.43 The 13C chemical shifts (ppm) (125.77 MHz) of C-1, C-3 and C-2' of 0.738-0.527 
M streptomycin were measured relative to TMSP in 99.97% D2O at 25°C at different pHs 
pH C-1 C-3 C-2' 
4.61 60.55 60.92 63.34 
5.71 60.62 61.01 63.41 
8.07 60.64 61.01 64.58 
10.35 60.7 61.19 65.73 
11.15 60.71 61.48 65.81 
11.72 60.77 61.88 65.71 
12.22 61.11 62.77 65.71 
13.51 62.53 63.21 65.71 




Table 4.44 The 15N HMBC chemical shifts (ppm) (50.67 MHz) of N-1, N-3 and N-2' of 0.738-
0.527 M streptomycin were measured relative to CH3NO2 in 99.97% D2O at 25°C at different 
pHs 
pH N-1 N-3 N-2' 
4.61 96.83 96.02 44.49 
5.71 96.82 96.01 44.41 
8.07 96.82 96.01 40.21 
10.35 96.82 96.01 33.71 
11.15 96.77 95.82 33.82 
11.72 96.74 94.99 33.81 
12.22 96.41 94.71 33.81 
13.51 95.17 93.84 33.81 
14.11 94.81 93.23 33.81 
 
